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1. Introduction - Parathyroid hormone related protein 
Fuller Albright, in 1941 was first who reported a case with renal cell carcinoma, increased 
calcium and reduced phosphorus, in New England Journal of Medicine (Martin, Allan et al. 
1989). The parathyroid cancer was excluded in this patient, so he thought that hypercalcemia 
and low phosphorus might be a result of a parathyroid hormone (PTH)-like factor, produced and 
secreted by the cells, which could not be from the parathyroid glands (Martin, Allan et al. 1989).  
Later on using several anti-PTH sera, it was determined that PTH is not present in tumor 
samples from patients with hypercalcemic cancers. Thereby, it was deduced that a PTH-like 
substance causes the hypercalcemia derived from cancers, yielding the term humoral 
hypercalcemia of malignancy (HHM). This term indicates the hypercalcemic patients suffering 
from certain cancers without any metastasis in bone (Martin, Moseley et al. 1991).  
During 1980-1990, its role in the syndrome named as HHM, the peptide identification and 
cloning of the cDNA were established. Further research revealed more information about the 
peptide regarding its expression and function. It was clarified that a factor, structurally related to 
PTH and named PTH-related protein (PTHrP) is expressed under normal circumstances, in a 
large number of cells and organs such as teeth, mammary glands, cardiovascular system, 
placenta, smooth muscle, respiratory epithelial cells, renal cells etc. and in some forms of tumors 
(Philbrick, Wysolmerski et al. 1996).  
As indicated above, PTHrP firstly was discovered as a product of some solid tumors, nowadays 
it is considered to act in a paracrine, autocrine or intracrine manner under physiologic and 
pathologic conditions in numerous cells and tissues. Various biological effects have been 
attributed to its NH2–terminal, midregion and carboxyl regions. PTHrP peptides play a pivotal 
role in development of many tissues and can modify the growth, differentiation, proliferation, 
function, and death of various cell types (Strewler 2000).  
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1.1. Structural properties of parathyroid family 
PTHrP is a member of PTH family. This hormone family encompasses proteins with structural 
and functional similarities. The family members are parathyroid hormone (PTH), parathyroid 
hormone-related protein (PTHrP) and tuberoinfundibular peptide of 39 residues (TIP39) (Martin, 
Moseley et al. 1991). 
A great homology was discovered between PTH and PTHrP, as 8 of the first 13 amino acids 
were identical. This similarity in the amino acid residues goes down in the region between 14-34 
residues and thereafter there is no more resemblance. The structural similarities made it clear 
that this might have derived from gene duplication of a common ancestral gene, however it is 
still unknown which of them is the original gene (Suva, Winslow et al. 1987). PTHrP is encoded 
by PTHLH gene located on chromosome 12 (Suva, Mather et al. 1989), whereas PTH gene is 
located on chromosome 11 (Mannens, Slater et al. 1987). These two chromosomes are believed 
to derive from duplication process from a common ancestral chromosome (Comings 1972). 
PTH comprises an 84 amino acid chain. It is produced by parathyroid glands and plays an 
important role in calcium homeostasis. Despite the fact that the structure of these two peptide 
hormones resemble to each other, they express their effects in the same way in classical target 
cells as such osteoblasts, osteoclasts, chondrocytes and tubule cells deriving from bone and 
kidney, respectively, but distinct effects on other cells (Schluter 1999). 
PTHrP from rats is made up of 141 amino acids while in humans PTHrP family consists of three 
fragments (Schluter 1999) as such: PTHrP (-1–139), PTHrP (-1–141), and PTHrP (-1–173). 
Posttranslational modifications of these peptide fragments results in the generation of N-terminal 
and C-terminal PTHrP peptides. The N-terminal includes the region from 1-36 amino acids, 
which activates PTH1 receptor (Orloff, Reddy et al. (1994); Philbrick, Wysolmerski et al. (1996)). 
Mid-region includes peptides 38-94, 38-95, and 38-101 (Soifer, Dee et al. 1992) which is thought 
to modulate renal bicarbonate handling and stimulates the placental calcium transport needed 
for fetal skeletal development (Kovacs, Lanske et al. 1996). The C-terminal includes peptides 
107-138 and 109-138, a region that inhibits osteoclast function and stimulates osteoblast 
proliferation. The actions regarding mid-region and the C-terminal of PTHrP are supposed to be 
mediated by other receptors than PTH1, receptors specific to these PTHrP regions, which are 
not yet known (Philbrick, Wysolmerski et al. 1996). 
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PTHrP displays its effects in an autocrine/paracrine fashion but also via a so-called intracrine 
pathway. The later one includes the translocation of the nascent protein into the nucleus. So 
that, PTHrP in its 88 ± 107 amino acid region carries a nuclear localization sequence (NLS), a 
sequence similar to the NLS in mammalian and viral transcription factors. This region of PTHrP 
regulates cell proliferation and apoptotic cell death (Clemens, Cormier et al. 2001).   
Even though PTH and PTHrP bare some resemblance, they vary from each other as follows 
(Schluter 1999): 
 the peptide chain of PTHrP is longer, being extended at the C-terminal 
 PTHrP is expressed under physiological and malignant conditions 
 PTHrP displays the effects in a paracrine and autocrine fashion  
 
As regards TIP39, its structure slightly resembles the two other peptides of the parathyroid 
family. It has four amino acids similar to both PTH and PTHrP, and six amino acids identical with 
PTH (Usdin, Wang et al. 2000). However, high resolution NMR studies point out homology in 
three-dimensional structure between peptides (Piserchio, Usdin et al. 2000). TIP39 is 
predominantly expressed in two regions of the brain, and it is considered as a neuroendocrine 
hormone that regulates the stress response and body temperature (Dobolyi, Dimitrov et al. 
2012).  
 
1.2. Receptors of parathyroid family 
The significant sequence homology between PTH and PTHrP gives the opportunity to bind and 
activate a common receptor, the so-called PTH-1R, or PTH/PTHrP receptor cloned in rat, 
mouse, and human. Actually, the N-terminal part (34 amino acids) of PTH and the amino-
terminal peptides of PTHrP share the same receptor-binding domain. However, the midregion 
and osteostatin peptides bind other receptors, specific to these domains of PTHrP (Mannstadt, 
Juppner et al. 1999). 
PTH-1R is a member of secretin family of G-protein coupled receptor (GPCR) with seven 
membrane helixes (Abou-Samra, Juppner et al. 1992). It is mainly expressed in kidney and 
skeletal tissues but it is present in various other tissues as well. In kidney and bone, it is 
important in the PTH-dependent regulation of mineral ion homeostasis. It mediates the 
autocrine/paracrine actions of PTHrP as endochondral bone formation (Juppner, Abou-Samra et 
al. 1991). 
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The type II receptor binds both PTH and TIP39, except PTHrP (Usdin, Gruber et al. 1995). PTH2 
receptor is more located in brain and testes, and to a less extent in other tissues (Usdin, Bonner 
et al. 1996). TIP39 has a quite distinct structure than PTH and PTHrP and much more ability 
than PTH to activate selectively the type II receptor and consequently the adenylyl cyclase 
pathway (Clemens, Cormier et al. 2001).  
 
1.3. Classical signal transduction pathways of PTHrP 
As mentioned previously amino terminal fragments of PTHrP (1-36) and PTH (1-34) act through 
the same receptor, the PTH-1R. It is believed that the type I receptor may be an essential 
pharmacological target for curing some functional disorders like HHM, mineral ion homeostasis, 
and osteoporosis (Clemens, Cormier et al. 2001).  
Binding and activating the PTH-1R by one of the abovementioned peptides leads to activation of 
two second messenger pathways: the adenylyl cyclase/protein kinase A signalling pathway and 
the phospholipase C/protein kinase C signalling pathway. As PTHrP binds to G-protein coupled 
receptor, via stimulatory G-alpha proteins (Gαs), it activates adenylate cyclase (AC)  and makes 
feasible the formation of cyclic 3`, 5`-adenosine monophosphate (cAMP). Afterward, cAMP 
activates protein kinase A (PKA) in these cell types: kidney cells, vascular smooth muscle cells, 
chondrocytes, and osteoblasts (Loveys, Gelb et al. (1993); Maeda, Wu et al. (1996)). 
In the case when PTHrP signals via G-α proteins (Gαq) (in other target cells like pancreatic islet 
cells and carcinoma cells), it activates phospholipase C (PLC) β, causing the diacylglycerol  
(DAG) formation and this leads to protein kinase C (PKC) activation and 1,4,5 inositol 
triphosphate (IP3) formation and consequently, the level of  intracellular free Ca2+ is elevated. 
MCF-7 breast cancer cells and skin fibroblasts were suggested as the probable case where after 
binding of PTHrP to PTH-1R, the both pathways mentioned above can be activated (Fortino, 
Torricelli et al. (2002); Maioli, Fortino et al. (2002); Maioli and Fortino (2004)). 
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1.4. Physiological effects of PTHrP 
In spite of the fact that PTHrP was discovered as a factor released from tumors, it acts locally in 
many tissues as a paracrine, autocrine or intracrine factor regulating a wide variety of 
physiological processes. There are some cases, that some PTHrP species, unknown till now, act 
as endocrine factor and are present in the circulation (Suva, Winslow et al. (1987); Lippuner, 
Zehnder et al. (1996); Hiremath and Wysolmerski (2013); Vanhouten and Wysolmerski (2013)) 
as: 
 in humoral hypercalcemia of malignancy, where the peptide is released from the tumor 
 during fetal development, in which case the peptide is produced by the parathyroid 
glands of the fetus and manages the placental calcium transport 
 lactation where PTHrP is produced in the mother’s breast and is present in the circulation 
 
1.4.1. Cardiovascular system 
Atrial and ventricular cardiomyocytes, smooth muscle cells, and pacemaker cells constitute the 
target cells for PTHrP in the cardiovascular system. The peptide is expressed in different cells as 
endothelial cells, atrial cardiomyocytes, and smooth muscle cells of the cardiovascular system. 
Cardiac myocytes and smooth muscle cells express PTHrP and the corresponding receptor 
PTH-1R thereby, activating PKA, a pathway, which leads to vasorelaxation (Schluter and Piper 
1998). Moreover, PTHrP is believed to be involved in the proliferation of vascular smooth muscle 
cells, suggesting that the peptide may have an important role in vascular remodelling, 
specifically in the development of neointima after arterial injury (Pirola, Wang et al. (1993); 
Maeda, Wu et al. (1996); Massfelder, Fiaschi-Taesch et al. (1998); Song, Fiaschi-Taesch et al. 
(2009)). PTHrP knockout mice experiments demonstrate higher proliferation rate of vascular 
smooth muscle cells compared to the wild-type mice. This indicates that PTHrP may play a role 
as a physiological regulator of vascular smooth muscle cell proliferation (Massfelder, Dann et al. 
1997). 
Under circumstances like mechanical deformation of the arterial wall, release of a 
vasoconstrictor substance as angiotensin II, or arterial pressure increase, the production of 
PTHrP increases. In such cases, PTHrP acts through its receptor PTH-1R activating PKA and 
relaxing the vasculature. Vasoconstrictors that lead to the increase of PTHrP mRNA and protein 
levels are endothelin, angiotensin II, noradrenaline (Pirola, Wang et al. 1993). 
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PTHrP (1-34) exerts positive chronotropic and inotropic effects on isolated and perfused rat 
hearts (Nickols, Nana et al. 1989) but on cellular level, to be more specific in adult ventricular 
cardiomyocytes, it activates adenylate cyclase and stimulates their contractile response 
(Schluter, Weber et al. (1995); Schluter, Weber et al. (1997)). 
 
 1.4.2. The Skeleton 
Researchers investigating the HHM syndrome found out the circulating PTHrP protein as a 
source of series events happening in this disorder. This discovery urged the scientists to study 
more and more the functions and effects of this peptide hormone (Suva, Winslow et al. 1987). 
As a result, it was detected that PTHrP shows a variety of actions including smooth muscle 
relaxation and regulation of cellular proliferation and differentiation (Strewler 2000). 
The genesis of mesenchymal condensations indicates the starting of bone development. Groups 
of mesenchymal cells gather and initiate a genetic program. In some of the bones as in the flat 
bones of the skull, these collections then directly differentiate into osteoblasts. However, there 
are a great number of bones where mesenchymal cells differentiate into chondrocytes and an 
adjacent perichondrium. Endochondral bone formation is a process, which makes feasible the 
chondrocytes conduct the differentiation of perichondrial cells into osteoblasts (Kronenberg 
2003). 
PTHrP is released from chondrocytes and is very important for endochondral bone formation. 
The peptide is released firstly by immature chondrocytic cells in response to a molecule the so-
called Indian Hedgehog (IHH) secreted by differentiating hypertrophic chondrocytes. Then 
PTHrP triggers the corresponding receptor the PTH-1R, found in proliferating and 
prehypertrophic cells, and carries on their proliferation and decelerates the differentiation into 
hypertrophic cells. This is the way, how these both molecules IHH and PTHrP cooperate in order 
to regulate the chondrocyte differentiation. It was proved that the amino terminal PTHrP interacts 
with the corresponding receptor the PTH-1R, in order to maintain the continuation of 
chondrocyte differentiation, and regulating the growth of long bones during development 
(Kronenberg 2006). 
As it is shown in Fig.1, on chondrocytes PTHrP displays its actions via the PTH-1R, whereby it 
stimulates Gs, cAMP production and protein kinase A activity. Thereafter a chain of downstream  
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processes is thought to take place as the inhibition of p57 expression, Bcl-2 and cyclin D1 
expression, the induction of Gli3, the phosphorylation of SOX9, and the phosphorylation and 
degradation of Runx2 and Runx3. The latest ones Runx2 and Runx3 are important transcription 
factors for chondrocyte differentiation (Hilton, Tu et al. (2005); Koziel, Wuelling et al. (2005); 
Kronenberg (2006)). Signalling pathways shown here and certainly multiple others, which 
support them are involved in the process of bone development.   
 
 
Figure 1. Intracellular signalling pathway of PTH/PTHrP receptor on chondrocytes (modified from 
Kronenberg 2006). 
 
1.4.3. Mammary Gland 
PTHrP is widely distributed in a variety of non-malignant tissues, and plays a pivotal role during 
fetal organogenesis and tissue differentiation (Ferrari, Rizzoli et al. 1994). 
Mammary epithelial cells express PTHrP since initial phases of mammary gland development. In 
mice, at the stage when mammary bud formation starts, PTHrP is produced in epithelial cells. 
Furthermore, the peptide interacts with its corresponding receptor PTH-1R found on nearby 
mesenchymal cells. The loss of this signalling as in the case of PTHrP or PTH-1R knockout mice 
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causes a discontinuity of the interaction between epithelial and mesenchymal cells 
(Wysolmerski, Cormier et al. 2001). 
During mammary gland development if the expression of PTH-1R is reduced it may influence the 
nipple formation and delivering of milk during lactation (Kuenzi and Sherwood 1995). According 
to this study, during mammary gland development, decreased PTH-1R signalling correlate with 
reduced smooth muscle. Smooth muscle cells are influenced from relaxin action in the nipple 
and in numerous other tissues (Kuenzi and Sherwood 1995). Relaxin is a peptide hormone that 
belongs to insulin family and in female is produced by placenta, during pregnancy, corpus 
luteum of the ovary and breast. Relaxin knockout mice model shows that, nipples in the absence 
of relaxin does not grow during pregnancy. The study suggests that failure of nipple growth 
during pregnancy is because small size of smooth muscle beds and absence of connective 
tissue remodeling. Finally, during mammary gland development, the main cause of this reduced 
receptor signalling is a mesenchyme, which later on is capable of producing enough smooth 
muscle in the nipple, the important factor for regulating processes during pregnancy and 
lactation (Zhao, Roche et al. 1999). 
The PTHrP role except during breast development, it was found to be important during lactation, 
where it regulates the systemic calcium metabolism. In lactation large amounts of calcium are 
needed and maternal skeleton is considered as a supplier of that in order to produce milk 
(Kovacs 2001). During lactation, CaR is also expressed from the breast, which regulates PTHrP 
secretion in reply to calcium transport to the breast. In the case of increased calcium transport to 
the breast, it suppresses PTHrP secretion (VanHouten, Dann et al. 2004). 
 
1.4.4. Placenta 
Calcium transport is a crucial process during pregnancy, accomplished through placenta from 
mother to fetus. PTHrP seems to be very important in promoting calcium transport seeing that 
PTHrP deficient fetuses are hypocalcemic. Moreover, the calcium is transported against a 
gradient, so there is a higher calcium concentration in fetus than in the mother (Kovacs, Lanske 
et al. 1996).  
PTHrP is essential for maintenance of normal fetal calcium concentration (Kovacs 2001). The 
peptide is secreted from placenta and this is regulated by CaSR (Kovacs, Ho-Pao et al. 1998). It 
was shown that responsible for placental calcium transport is particularly the midregion of PTHrP 
(Kovacs, Lanske et al. 1996). 
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1.4.5. Renal effects  
The presence of PTHrP in the normal fetal and adult kidney was proved by a variety of studies. It 
binds to an abundant PTH1 receptor (Lee, Brown et al. 1996). In kidney, PTHrP and PTH-1R are 
expressed in the vascular smooth muscle cells where PTHrP displays vasorelaxant effects 
(Clemens, Cormier et al. 2001). Studies performed in transgenic mice show that overexpression 
of the peptide or the corresponding receptor in the arterial wall of the animals yield hypotensive 
effects, a case that is thought to be mediated by NO and cAMP (Qian, Lorenz et al. 1999). 
Numerous cellular responses to PTHrP are mediated by cAMP. One of them, the so called 
phosphaturic response takes place via protein kinase A increase and protein kinase C-mediated 
internalization of the (Type II) Na/PO4 co-transporter which lead to reduced phosphate 
reabsorption (Murer, Hernando et al. 2003). 
It was suggested that local PTHrP influences the glomerular filtration rate in the glomerulus. 
Locally administered N-terminal portion PTHrP in hydronephrotic rat kidney model resulted in 
vasodilatation of preglomerular vascular segments and renal blood flow increase (Endlich, 
Massfelder et al. 1995). In addition to that, increase in glomerular filtration rate and urine flow 
was observed when infusion of N-terminal portion PTHrP was administered intrarenal into the 
left renal artery of anaesthetized rats (Massfelder, Parekh et al. 1996). These studies suggest 
that locally secreted PTHrP may be involved in the glomerular filtration rate and renal blood flow. 
In renal tubular cells PTHrP enhances the reabsorption of calcium in the distal tubule, however 
inhibits the reabsorption of bicarbonate and phosphate and Na+/H+ exchange. In the renal 
proximal tubule, it induces the activity of 1α-hydroxylase enzyme (Maeda, Wu et al. 1998). 
However, numerous studies suggest the involvement of PTHrP in various kidney diseases. 
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1.5. Role of PTHrP in Lung Development, Homeostasis and Repair 
The lung is an organ, which enables the gas exchange. Lung development and maturation is 
crucial for survival especially during the transition to postnatal life (Jobe and Ikegami 2001). 
Branching morphogenesis and alveolization (Torday 2014) are two stages of mammalian 
embryonic lung development.  
PTHrP is a stretch-regulated (Torday and Rehan 2002) gene implicated in lung development. It 
is essential for the formation of alveoli, structures necessary for adaptation to cyclic 
inspiration/expiration of oxygen and CO2 (Torday and Rehan 2004). It was proved that lack of 
PTHrP gene leads to failure to form alveoli, which is lethal for the newborn due to pulmonary 
insufficiency (Torday and Rehan 2004).  
As shown in Fig. 2, pulmonary PTHrP is expressed in alveolar type II cells, and PTH-1R 
localizes nearby, in the adepithelial mesenchyme. The expression pattern of both enables 
formation of a paracrine loop for epithelial mesodermal interactions, which is considered an 
important pathway regarding lung development, homeostasis, and repair (Doi, Lukosiute et al. 
2010).  
 
 
Figure 2. Model of lung evolution, development, homeostasis, and repair (modified from Torday and 
Rehan 2007). 
11 
 
The left side of the figure displays the comparison between lung evolution from the fish swim 
bladder to the mammalian lung and the development of the mammalian lung. It is evident that 
alveoli get smaller through phylogeny, alveolar myofibroblasts decrease and lipofibroblasts 
increase (Torday 2014).  
The right part of the figure demonstrates the importance of the epithelial-mesenchymal cross-
talk for lung homeostasis. PTHrP stimulates surfactant production through this paracrine 
feedback loop between lung endoderm and mesoderm. Binding of PTHrP to its receptor 
downregulates the myofibroblast Wnt signalling and upregulates the cyclic AMP-dependent 
Protein Kinase A (PKA) signalling pathway. Stimulation of this signalling pathway leads to 
upregulation of the interstitial lipofibroblast differentiation, PTH1R, and downstream molecules 
like ADRP, leptin, triglyceride uptake, by stimulating PPAR-γ expression (Torday, Torres et al. 
2003). Leptin secreted from lipofibroblasts binds to the type II cell leptin receptor, and stimulates 
the differentiation of the epithelial type II cell (Torday, Sun et al. 2002), a process determined by 
epithelial-mesenchymal cell interactions (Rutter, Pictet et al. 1978). Leptin by the paracrine 
mechanism (from epithelium to mesenchyme and back to epithelium) stimulates the surfactant 
production and protein synthesis by epithelial type II cells (Kirwin, Bhandari et al. 2006). 
The synthesis and secretion of surfactant increases late in gestation when the lungs of fetus are 
already matured (Kirwin, Bhandari et al. 2006), and is particularly essential for survival at the 
time of transition from intrauterine to extrauterine life. It reduces the surface tension at this 
period, thus preserving the stability of lung and preventing the collapse of alveoli (Kirwin, 
Bhandari et al. 2006). Pulmonary surfactant is composed of proteins, phospholipids, 
carbohydrate, and lipids. Phospholipids (Torday and Rehan 2002) are responsible for reducing 
the surface tension. ADRP is thought to be necessary for uptake, storage, and trafficking of 
neutral lipid from lipofibroblast to the alveolar type II cell for surfactant production (Schultz, 
Torres et al. 2002).  
It was shown that any impairment to the epithelium caused by nicotine, infection, prematurity 
(Cerny, Torday et al. 2008) or lack of PTHrP (Torday, Torres et al. 2003) impair the cross-talk 
between epithelium and mesoderm. In this case, Wnt signalling increases, PTH1R and 
downstream molecules are downregulated, lipofibroblasts transdifferentiate to myofibroblasts, 
condition that may lead to loss of homeostasis and eventually to lung fibrosis (Torday, Torres et 
al. 2003) or other chronic lung diseases. The model of lung evolution, development, 
homeostasis, and repair (Torday and Rehan 2007) is a key point regarding novel diagnostic and 
therapeutic targets. 
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1.6. Role of PTHrP in Sepsis 
Sepsis is a systemic immune response to infection. It can result in multiple organ dysfunction 
syndrome (earlier named as multiple organ failure) and death, which indicates severe sepsis. 
Septic shock implies a condition with inappropriate organ function due to insufficient blood 
supply, hypotension, leading to ischemia and particularly collapse of the cardiovascular system 
(Nemzek, Hugunin et al. 2008).  
In research experiments, a cell wall component of gram-negative bacteria-lipopolysaccharide 
(LPS) is used to create a sepsis model to investigate the inflammatory response. Humans are 
considered more sensitive to LPS dose. Therefore, the dose administered to animal is generally 
250 times higher than the dose causing sepsis in humans (Copeland, Warren et al. 2005).  
Tumor necrosis factor (TNF) was firstly discovered by (Carswell, Old et al. 1975) as a pro-
inflammatory cytokine, an important mediator of inflammation. Funk, Krul et al. (1993) found the 
role of PTHrP in an animal model of endotoxemia. When sublethal dose of lipopolysaccharide 
(LPS) was used, it increased markedly the PTHrP mRNA in the spleen. TNF was found to be an 
important mediator of the LPS induced splenic PTHrP expression. Thus, it was suggested that 
PTHrP could be a member of the cascade of proteins, which is induced during innate immunity 
response to a local injury. In this model PTHrP expression was elevated following increase of 
cytokines like TNF and interleukin-1 (IL-1). However, circulating PTHrP levels were not 
noticeable. 
Later on, Dinarello (2000) proposed a pathway (Fig.3) relating to inflammatory cytokines, in 
particular TNF and IL-1 which by targeting the endothelium they initiate a cascade of 
inflammatory mediators in response to infection, ischemia, or toxins.  
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Figure 3. Inflammatory pathway initiated by TNF and IL-1 (modified from Dinarello 2000). 
 
Studies performed by Funk, Moser et al. (1996) using near lethal dose of endotoxin to create an 
overwhelming sepsis model found that PTHrP mRNA expression was induced in heart, liver, 
kidney, lung and spleen. PTHrP serum levels were also increased, reaching the peak at two 
hours, just as mRNA levels in the investigated vital organs, suggesting that systemic levels 
increased as e result of increasing the local PTHrP levels. Therefore, Funk, Moser et al. (1996) 
illustrated the inflammatory pathway triggered by TNF and IL-1 adding PTHrP as an 
inflammatory mediator being induced following the increase of cytokines. 
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Figure 4. Pathway of cytokines and PTHrP in injury (Funk, Moser et al. 1996). 
Hypotension is considered as an important factor among many unknown ones to cause the 
death from sepsis. PTHrP mRNA expression was found to be induced in smooth muscle cells in 
spleen after a sublethal dose of LPS administration (Funk, Krul et al. 1993). When a lethal dose 
of endotoxin was administered to the animal, PTHrP as a vasodilator (Takahashi, Inoue et al. 
(1995); Maeda, Sutliff et al. (1999)) extremely dilated the vessels, decreased the systemic 
vascular resistance, causing hypotension and multiple organ failure which lead to mortality 
(Funk, Moser et al. 1996).  
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1.7. Obesity Paradox 
Accumulation of the excessive body fat is known as obesity (Childers and Allison 2010). It is a 
complex medical condition contributing to detrimental health effects. It is a risk factor for 
numerous chronic diseases like type 2 diabetes, heart diseases, etc (Vendrell, Broch et al. 
2004).  
Despite the fact that obesity impairs the health and reduces the lifespan, decreasing the calories 
in diet proved to increase the life span. There are three explanations of the phenomenon 
(Childers and Allison 2010):  
 The U-shaped curve which describes the relation between the BMI and the risk of 
mortality. The finding suggests that people with relatively highest and lowest BMI are 
associated with increased mortality risk than people with intermediate BMI. 
 The second one displays the nadir of the U-shaped curve that increases with age. It was 
found to be higher in older compared to younger people.  
 Obesity paradox, the phenomenon firstly described in 1999, indicating better survival of 
obese hemodialysis patients (Schmidt and Salahudeen 2007). Later on was found that 
obesity-survival paradox is linked to other clinical settings as well, like congestive heart 
failure (Schmidt and Salahudeen 2007), myocardial infarction (Wang, Liu et al. 2016), 
acute coronary syndrome (Niedziela, Hudzik et al. 2014). There is evidence that patients 
with increased BMI experiencing a cardiac disease may have a better prognosis 
compared to their leaner counterparts (Poncelas, Inserte et al. 2015). However, the 
mechanisms of this clinical paradox remain to be elucidated.  
Since Gruberg, Weissman et al. (2002) described the obesity paradox in cardiovascular disease, 
the phenomenon was analyzed by more researchers in this regard as well. The beneficial effect 
of it has been shown for a variety of cardiovascular diseases like myocardial infarction, atrial 
fibrillation, coronary bypass, hypertension, etc (Oga and Eseyin 2016). 
According to Poncelas, Inserte et al. (2015), high-fat diet decreased the consequences of LAD 
occlusion by reducing the infarct size and improving the left ventricular function in mice, 
supporting the beneficial effects of the paradox in ischemia/reperfusion. Obesity contributes to a 
proinflammatory state (Vendrell, Broch et al. 2004), and there is a deficiency in regulation of pro-
and anti-inflammatory factors. Poncelas, Inserte et al. (2015) proved a significant increase in 
plasma levels of TNF-α, resistin and leptin in the HFD mice fed for 6 months.  
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The cardioprotective effect of obesity might be associated with modifications in cytokines, leptin 
and insulin before the ischemic event. Moreover, the study suggests that dietary obesity with 
hyperinsulinemia and without hyperglycemia or hypertension reduces negative influences of 
ischemia/reperfusion injury by increasing insulin signalling and RISK activation. 
Donner, Headrick et al. (2013) investigated the impact of dietary obesity in an insulin-insensitive 
rat model. The finding implies that obesity could be beneficial in case of insulin insensitivity, 
suggesting cardioprotection, which can happen via reperfusion injury salvage kinase (RISK) 
signalling. Data indicate that insulin resistance is a key factor that damages the resistance to 
ischemia/reperfusion. 
However, obesity is a complex disorder linked to a number of co-morbidities like inflammation, 
dislipidaemia, hyperglycaemia, oxidative stress and overt diabetes (Donner, Headrick et al. 
2013). The relation between these factors and obesity remain unclear. Despite the fact that 
weight loss alleviates the symptoms of the cardiovascular diseases and thereby improves the 
cardiac function, there is no official evidence regarding optimal body weight for patients suffering 
from a cardiovascular disease (Lavie, Sharma et al. 2016). 
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1.8. Cardiac ischemia/reperfusion 
Myocardial ischemia is a case that occurs because of partial or complete occlusion of coronary 
arteries. Therefore, there is a deficiency in blood flow and oxygen to tissues, which leads to not 
sufficient oxygen-rich blood. Most importantly is the rearrangement of the blood flow to tissues 
as quickly as possible (Kalogeris, Baines et al. 2012). 
Myocardial infarction, peripheral vascular disease and stroke are common disorders that worsen 
the disease and lead to death. Duration, size of ischemia and the injury caused by following 
reperfusion are crucial regarding tissue damage or death (Kalogeris, Baines et al. 2012). 
Cardiac injury induced by myocardial infarction leads to damage and loss of cardiomyocytes. 
This is followed by induction of innate immune pathways that activates the inflammatory 
response. The inflammatory cascade helps to heal and repair the myocardium by removing the 
dead cells and matrix fragments and finally formation of a scar (Frangogiannis 2008). With the 
onset of reperfusion the blood flow and oxygen reaches the tissues, however reperfusion has 
harmful consequences. The release of ROS and proinflammatory neutrophils that penetrate the 
ischemic tissue worsen the damage to the cells (Kalogeris, Baines et al. 2012).  
Simultaneously, activation of macrophages and mast cells contribute to the release of 
inflammatory molecules, chemokines, and cytokines like TNFα, IL-1, IL-6, LTB4, etc. that 
participate in ischemia/reperfusion injury (Rodrigues and Granger 2010). In general, ischemia 
causes the hydrogen, intracellular sodium and calcium ions to be collected and induce tissue 
acidosis. On the other hand, reperfusion stimulates changes in ion flux, however, the swift 
restoration of blood flow and pH deteriorates the cell and tissue injury (Turer and Hill 2010).  
Particularly, lung is the organ, which gets the whole stroke volume of the heart. Therefore, 
dysfunction of the left ventricle may cause impairment in the right ventricle and lung function 
(Torday, Torres et al. 2003). Usual complications after the myocardial infarction are pulmonary 
hypertension and lung remodeling (Jasmin, Calderone et al. (2003); Jasmin, Mercier et al. 
(2004)). A pivotal role in pulmonary remodelling and structure formation of the lung has PTHrP. 
As mentioned before, it binds to and activates the PTH1R, which leads to activation of adenylyl 
cyclase, thereafter, cAMP production and activation of PKA. Activation of this signalling pathway 
in lung increases the expression of ADRP, PPARγ leptin, contributing to surfactant synthesis 
and thereby inhibiting the transdifferentiation of lipofibroblasts into myofibroblasts (Rehan, 
Sakurai et al. 2007). Absence of interaction between PTHrP and its corresponding receptor 
causes the myofibroblast formation that leads to pulmonary stiffness and fibrosis (Torday, Torres 
et al. 2003). 
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1.7. Aims of the study 
PTHrP is considered as a peptide hormone having a great impact on biological processes in 
various tissues. However, the role of PTHrP in pulmonary remodeling following the left 
ventricular ischemia/reperfusion, the effect of high fat diet on its pulmonary expression and the 
influence of sepsis is not yet elucidated. Therefore, our aims of investigation were as follows:  
- To analyze the effect of high fat diet and ageing on PTHrP tissue expression under  
ischemia/reperfusion 
- To identify a possible role for PTHrP in sepsis and the modification by hypothermia that 
allows protecting tissues from the consequences of sepsis. 
In order to reach these aims, tissue samples from mice fed with either normal or high fat diet that 
underwent an established ischemia/reperfusion protocol; pigs that underwent an established 
protocol of simulated sepsis; isolated perfused rat hearts; and rat ventricular myocytes were 
used for analysis. 
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2. Materials and Methods 
2.1. Materials 
2.1.1. Chemicals 
Table 1. Chemicals systematically used during the study 
Chemical Manufacturer 
PeqGold TriFastTM (Trizol) PEQLAB, Biotechnology GmbH, Germany 
Ethanol Roth, Karlsruhe, Germany 
Chloroform Roth, Karlsruhe, Germany 
Isopropanol Sigma-Aldrich Chemie GmbH, Steinheim, Germany 
Aqua bidest. B. Braun Melsungen AG, Melsungen Germany 
5xRT Buffer Invitrogen, Karlsruhe, Germany 
Oligo-dt Roche, Mannheim, Germany 
dNTP’s Invitrogen, Karlsruhe, Germany 
Dithiotreitol Invitrogen, Karlsruhe, Germany 
RNAsin Promega, Madison, USA 
M-MLV Reverse Transcriptase Invitrogen, Karlsruhe, Germany 
Absolute™ SYBR Green Fluorescein 
qPCR-Mix Thermo Scientific, UK 
Lysis Buffer Cell Signalling Technology,  
PMSF Roth, Karlsruhe, Germany 
Laemmli Buffer 2x concentrate Sigma-Aldrich Inc., SaintLouis, Missouri, USA 
SDS-PAGE broad range protein ladder 
(molecular weight marker) Thermo Scientific Inc., MA, USA 
NuPAGE® MOPS SDS Running Buffer Life Technologies, CA, USA 
NuPAGE® Antioxidant  Life Technologies, CA, USA 
Bovine Serum Albumin 5% Roth, Carl Roth GmbH+Co.KG, Karlsruhe, Germany 
10xTBS Buffer KPL, Gaithersburg, USA 
Tween20 AppliChem GmbH, Darmstadt, Germany 
NuPAGE® Transfer Buffer Life Technologies, CA, USA 
Methanol Roth, Karlsruhe, Germany 
20 
 
Peroxide solution (ECL reagent) Life Technologies, CA,USA 
Luminol Enhancer solution (ECL reagent) Life Technologies, CA,USA 
LPS from Escherichia coli O111:B4 Sigma-Aldrich Inc., SaintLouis, Missouri, USA 
RNase AWAY Molecular BioProducts, San Diego, CA 
Collagenase (crude collagenase from 
clostridium histolyticum) Type 2 Worthington Biochemical Corporation, USA 
NaCl Merck, Darmstadt, Germany 
KCl Merck, Darmstadt, Germany 
KH2PO4 Merck, Darmstadt, Germany 
Hepes Roche, Mannheim, Germany 
CaCl2 Merck, Darmstadt, Germany 
Glucose-Monohydrate Merck, Darmstadt, Germany 
M199 Biochrom, Berlin, Germany 
Creatine Sigma-Aldrich Inc., SaintLouis, Missouri, USA 
Carnitine Sigma-Aldrich Inc., SaintLouis, Missouri, USA 
Taurine Sigma-Aldrich Inc., SaintLouis, Missouri, USA 
Cytosin-Arabinofuranoside Sigma-Aldrich Inc., SaintLouis, Missouri, USA 
FCS (4%) PAA Laboratories, Austria 
Penicillin gibco by Life Technologies, USA 
Streptomycin gibco by Life Technologies, USA 
PTHrP(1-34) Bachem , Weil am Rhein, Germany 
PTHrP(7-34) Bachem , Weil am Rhein, Germany 
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2.1.2. Antibodies 
Table 2. Primary antibodies 
Antibody Host Concentration Manufacturer 
Anti-Actin  rabbit 1:1000 Sigma, Taufkirchen 
Anti-PTHLP  rabbit 1:1000 Calbiochem, USA 
Anti-PTH/PTHrP 
receptor  mouse 1:100 
Sigma-Aldrich Inc., SaintLouis, 
Missouri, USA 
Phospho-p42 rabbit 1:1000 Cell Signalling Technology, USA 
p42 (ERK-2) rabbit 1:1000 Santa Cruz Biotechnology, USA 
 
Table 3. Secondary antibodies 
Antibody Concentration Manufacturer 
Sheep anti-rabbit IgG 1:1000 Affinity Biologicals, Ontario, Canada 
Goat anti-mouse 1:1000 Affinity Biologicals, Ontario, Canada 
 
 
2.1.3. Primers used in qPCR experiments 
Primers used in the study were provided from Invitrogen GmbH, Karlsruhe, Germany. 
Table 4. Mouse primers 
Gene Annealing temp (°C) 
Sequence 
Forward  Reverse 
B2M 60 GCT ATC CAG AAA ACC CCT CAA CAT GTC TCG ATC CCA GTA GAC GGT 
HPRT 59 CCA GCG TCG TGA TTA GCG AT CAA GTC TTT CAG TCC TGT CC 
PTHrP 60 GAG ATC CAC ACA GCC GAA AT CGT CTC CAC CTT GTT GGT TT 
PTH-1R 66 TTG CCT CCC TCA CCG TGG CT CGG CGC GCA GCA TAA ACG AC 
ADRP 60 CCC GCA ACC TGA CCC AGC AG CGC CTG CCA TCA CCC CCA AG 
PPAR-γ 61 GCC TTG CTG TGG GGA TGT TCA GCG GGA AGG ACT TTA TGT 
Elastin 60 CTG CTG CTA AGG CTG CTA AG CCA CCA ACA CCA GGA ATG C 
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Table 5. Pig primers 
Gene Annealing temp (°C) 
Sequence 
Forward  Reverse 
GAPDH 64 GATTTGGCCGCATCGGGCG CGCCTTGACTGTGCCGTGGA 
PTHrP 65 GCCACTGAAGACACCGGGCA CCCACTCCCGACCATGCTGC 
PTH-1R 65 GGTAGCAGGCACCAAGGGCG CCCAGCTGCCATTGCGGTCA 
ADRP 64 ACGCCCCTCAACTGGCTGGT TCACCTGACTGGCTGCCCCA 
Bcl-2 65 TGAACCGGCACCTGCACACC GCTCCCACCAGGGCCAGACT 
MCP-1 66 CAGCCACCTTCTGCACCCAGG CACAGATCTCCTTGCCCGCGA 
TGF-β1 63 TTCACGGCATGAACCGGCCC TGCCGCACGCAGCAGTTCTT 
Collagen-1 66 CCTCCTGACGCACGGCCAAG CTGGCAGGGCACGGGTTTCC 
 
Table 6. Rat primers 
Gene Annealing temp (°C) 
Sequence 
Forward  Reverse 
HPRT 63 CCAGCGTCGTGATTAGTGAT CAAGTCTTTCAGTCCTGTCC 
PTHrP 55 AGCTACTCCGTGCCCTCCCG AGGAAGAAACGGCGGCGCAA 
PTH-1R 64 GGCTGCACTGCACGCGCAA TTGCGCTTGAAGTCCAACGC 
MCP-1 63 TCACGCTTCTGGGCCTGTTGT TCCAGCCGACTCATTGGGATCA 
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2.1.4. Materials 
Table 7. Materials used consistently in experiments  
Material Manufacturer 
Pipettes Eppendorf – Netheler – Hinz, Hamburg, Germany 
Pipette tips Sarstedt AG&Co., Nümbrecht, Germany 
SafeSeal Tubes 0.5 ml; 1.5 ml; 2.0 ml Sarstedt AG&Co., Nümbrecht, Germany 
Precellys® ceramic beads PEQLAB, Biotechnology GMBH,Erlangen, Germany 
Scalpel Feather®, Japan 
0.2 ml 8-tube with domed cap, PCR 
strips Thermo Scientific, UK 
Latex balloon size 5 Harvard Apparatus, Qbiogene GmbH, Heidelberg, Germany 
Operation surgical thread Nr. 40 Gruschwitz GmbH Tech-Twists, Neu – Ulm, Germany 
NuPAGE® mini-gels Life technologies, CA, USA 
Nitrocellulose transfer membrane Whatman GmbH, Dassel, Germany  
Glassware Schott, Mainz, Germany 
Filter paper Biotec-Fischer GmbH , Reiskirchen, Germany 
Hamilton syringe (50 μl) Hamilton, Switzerland 
Tweezers Aesculap, Heidelberg, Germany 
Syringe B. Braun Melsungen AG, Melsungen, Germany 
Glass plate  Biometra, Göttingen, Germany 
pH-Meter WTW, Weilheim, Germany 
200 μm Nylon mesh neoLab, Heidelberg, Germany 
Parafilm Bemis Company, USA 
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2.1.5. Instruments 
Table 8. Instruments utilized during the study 
Instrument Manufacturer 
Laboratory scale Kern & Sohn GmbH, Balingen 
Precellys24 Homogenizer PEQLAB, Biotechnology GMBH, Germany 
Centrifuge Beckmann Coulter®, Krefeld, Germany 
UV equipment Stratagene®, CA, USA 
Vortex Minishaker IKA® Works, Inc., Wilmington, NC 
Thermal cycler Techne LTD, Cambridge, UK 
iCycler Bio-Rad, Munich, Germany 
NanoDrop® ND-1000 Spectrophotometer PEQLAB, Biotechnology GMBH, Germany 
Ultrasound apparatus (Sonoplus GM70) Bandelin, Berlin, Germany 
Block heater (Thermoblock) Labtech International, UK 
Langendorff apparatus  Institute of Physiology, Giessen 
XCell SureLock™ Mini-Cell 
Electrophoresis System Invitrogen™ by Life Technologies,CA, USA 
Shaker Biometra, Göttingen, Germany 
ECL imager PEQLAB, Biotechnology GMBH, Germany 
Mcllwain Tissue chopper Gala Gabler Laborbedarf, Bad Schwalbach, Germany 
 
2.1.6. Software 
Table 9. Software programs used in the study 
Software Manufacturer 
iCycler™ iQ Optical System Software BioRad, München, Germany 
NanoDrop 1000 V3.5.1  Coleman, München, Germany 
ChemiCapt 5000 Vilber Lourmat, France 
QuantityOne BioRad Laboratories, München, Germany 
Microsoft Office® Microsoft Deutschland, Unterschleißheim 
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2.2. Methods 
2.2.1. High fat diet, ageing, and ischemia/reperfusion in mice 
Tissue samples from animals undergoing ischemia-reperfusion and those administered to 
normal or high fat diet were analyzed in this study. Lung tissue samples were sent from 
Barcelona to Germany on dry ice. The following paragraph summarizes the experimental 
protocol. 
The animal handling and experimental studies were approved by Research Commission on 
Ethics of the Hospital Vall d’Hebron. All animal procedures conformed to EU Directive 
2010/63EU and Recommendation 2007/526/EC regarding the protection of animals used for 
experimental and other scientific purposes, enforced in Spanish law under Real 
Decreto1201/2005. 
The experimental sets were arranged in the way that half of mice from C57BL/6 model were fed 
with the appointed diet for 6 months and half of them for 12 months before a sham surgery or 
ischemia/reperfusion procedure was performed. 
6-week-old C57BL/6 mice were classified in two groups according to their diet. The first group 
was fed for 6 months with a standard diet containing 24% kcal from protein, 18% kcal from fat 
and 58% kcal from carbohydrate provided by Harlan Iberica (Barcelona). The other group was 
fed for 6 months with a high fat diet containing 20% kcal from protein, 60% kcal from fat and 
20% kcal from carbohydrate provided by Research Diets (New Brunswick, NJ). The type of high 
fat diet and other ingredients of diet induced obesity formula are shown in Table 10.  
After 6 months the mice were anesthetized by 2% isoflurane inhalation, orally intubated and 
mechanically ventilated (Inspira ASV, Harvard Apparatus). Afterwards sham surgery was applied 
to a group of animals (half of them fed with standard diet and half with high fat diet) and the 
other group of mice (half of them fed with standard diet and half with high fat diet) was subjected 
to ischemia where the left anterior descending coronary artery was occluded for 45 minutes. 
Reperfusion was the following procedure applied to the latter group for four weeks. In the study 
6-month-old mice were defined as 7 months and 12-month-old mice as 13 months because they 
were subjected to reperfusion for 4 weeks and after this period, the mice were sacrificed. Lungs 
were excised and frozen in liquid nitrogen up to further analysis. 
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Table 10. The diet induced obesity (DIO) formula 
Ingredient gm % Kcal % 
Casein, 80 Mesh 200 800 
L-Cystine 3 12 
Corn Starch  0 0 
Maltodextrin 10 125 500 
Sucrose 68.8 275 
Cellulose, BW200 50 0 
Soybean Oil 25 225 
Lard 245 2205 
Mineral Mix S10026 10 0 
DiCalcium Phosphate 13 0 
Calcium Carbonate 5.5 0 
Potassium Citrate, 1 H2O 16.5 0 
Vitamin Mix V10001 10 40 
Choline Bitartrate 2 0 
FD&C Blue Dye #1 0.05 0 
 
2.2.2. Experimental endotoxemia in vivo in pigs 
Tissue samples from pigs undergoing a model of simulated sepsis were analyzed in this study. 
Lung, left ventricle of the heart, liver, and aorta tissues from septic pigs were sent from Austria to 
Germany on dry ice. The following paragraph summarizes the experimental protocol. 
The experimental protocol was approved by the Austrian Bioethics Commission (BMWF-
66.010/0099-II/3b/2010) in Vienna and complies with the Guide for the Care and Use of 
Laboratory Animals published by the US National Institute of Health (NIH Publication No. 85-23, 
revised 1996). 
13 overnight-fasted landrace pigs (64±1 kg) were put under sedation with 0.5 mg/kg midazolam 
and 20 mg/kg ketamine. Pigs were anesthetized by 1mg/kg propofol and tracheotomy was 
performed using an endotracheal tube. Then sheaths were placed in both common carotid 
arteries (9F and 10F), both internal jugular veins (6F and 8F) and the left-sided femoral vein 
(14F). Throughout the procedure drugs like 1 % sevoflurane, 35 μg/kg/h fentanyl, 1.25 mg/kg/h 
midazolam, and 0.2 mg/kg/h pancouronium were used to maintain the anesthesia.  
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The respirator (volume-controlled mode) was set to 5 mmHg positive end-expiratory pressure, 
10 ml/kg tidal volume, I:E-ratio of 1:2 and 50% oxygen. The end-expiratory carbon dioxide partial 
pressure was retained between 35 and 40 mmHg setting the respiration rate. 
With the aid of sheaths, a Swan-Ganz catheter (Edwards Lifesciences CCO and Vigilance I, 
Edwards Lifesciences, Irvine, CA, USA) and a pacing probe were placed in the pulmonary artery 
and the right atrium of pigs, respectively.  
A catheter (5F, 12 electrodes, 7 mm spacing, MPVS Ultra, Millar Instruments, Houston, Texas, 
USA) for pressure conductance was inserted in the left ventricle and linked to a signal 
processing unit (MPVS Ultra, Millar Instruments, Houston, Texas, USA). In the descending aorta 
was inserted a valvuloplasty catheter (20 ml, Osypka, Rheinfelden, Germany), and an 
intravascular cooling catheter (Accutrol™ Catheter 14F, Philips Healthcare, Vienna, Austria) 
connected to a cooling device (InnerCool RTx Endovascular System, Philips Healthcare, Vienna, 
Austria) was put in the inferior vena cava. Using this intravascular cooling device the body 
temperature was kept constant at 38°C. 
Heparin bolus dose of 150 IU/kg and thereafter a continuous infusion of 75 IU/kg/h were given to 
prevent venous thrombosis. During the whole instrumentation period, a balanced crystalloid 
infusion (Elo-Mel Isoton, Fresenius) was given at a fixed rate of 10 ml/kg/h at room temperature. 
After the instrumentation procedure, pigs were let for 30 min to stabilize. 
 
2.2.2.1. Administration of LPS  
LPS infusion (E. coli serotype O111:B4, Sigma-Aldrich Inc., SaintLouis, Missouri, USA) in pilot 
experiments was administered at a rate of 10 μg/kg/h in 4 normothermic pig. 3-4 hours after the 
onset of LPS infusion 3 of 4 pigs died. Consequently, in the other set of experiments, the LPS 
dose was reduced to 0.5 μg/kg/h for 1 hour and 1.0 μg/kg/h for further 3 hours. So, LPS was 
given for 4 hours, and the pigs were observed for further 4 hours, overall a follow-up of 8 hours. 
Since the onset of LPS infusion, pigs were assigned consecutively 1:1 to either mild hypothermia 
(MH, n=8, 33°C) or normothermia (NT, n=8, 38°C). In MH group of animals, cooling was initiated 
at the same time with LPS administration by the intravascular device and infusion of ice-cold (4 
°C). Usually 3-4 hours after the onset of LPS infusion, the mean aortic pressure decreased lower 
than 55 mmHg. In this case, 4 boli of 500 ml crystalloid infusion were given. 1 μg/kg epinephrine 
was added in particular to the third and the forth bolus. In case where arterial oxygen saturation 
decreased below 90%, FiO2 was increased to 1.0, and the I:E-ratio was switched to 1:1. 
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Finally, the heart was checked and after verifying no coronary damage, the animals were 
sacrificed by a bolus of 80 mmol potassium chloride. 
 
2.2.3. Experimental endotoxemia in vitro in rats 
2.2.3.1. Isolated perfused rat heart assay - Principle 
Oscar Langendorff developed such a perfusion system for mammalian heart in 1895. 
Langendorff preparation is a method based on the perfusion of hearts and inspection of the 
cardiovascular parameters without having to take into consideration the problems or obstacles 
coming from the living animal. 
As shown in Fig.5 the Langendorff apparatus is coated with warm circulating water in order to 
keep the temperature of the heart and the fluid at 37°C. The heart removed from the animal is 
perfused by retrograde flow from aorta. This is named as retrograde perfusion because the fluid 
flows down into the aorta. In contrary, blood in situ, flows out of the left ventricle through the 
aorta.  
An oxygenated buffer is delivered to the heart via a cannula inserted into the ascending aorta. 
The buffer feeds the myocardium with the needed nutrients and oxygen, in order to function for 
hours after its excision from the animal. The reverse pressure of the buffer closes the leaflets of 
the aortic valve, as a consequence it does not allow the perfusate to enter the left ventricle but it 
permits it into the coronary arteries (naturally, they provide blood to the heart). Then, via 
coronary sinus the buffer gets into the right atrium and in the end it effuses via the right ventricle 
and pulmonary artery. The perfusion flow rate is kept constant during the experiment by either a 
constant hydrostatic pressure or constant flow rate. Systolic pressure under physiological 
conditions or in vivo experiments ranges from 70-90 mmHg. For the isolated heart it is 
recommended to be between 60-70 mmHg. Values higher than this range may cause 
incompetence of the aortic valve. 
Langendorff perfusion system is a useful tool in terms of estimating cardiac inotropic, 
chronotropic and vascular effects, malfunction, and effects of different pharmacological drugs on 
the cardiovascular system regarding metabolic activity, contractility, etc. 
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Figure 5. Langendorff heart perfusion model (modified from Chorro, Such-Belenguer et al. 2009). 
A. Oxygenation 95% O2, 5% CO2; B. Peristaltic pump; C. Filter; D. Tyrode solution; E. Heat sink; F. Pump; 
G. Heart; H. Flow/Pressure regulator;  I. Stimulator;; J. PC; K. Data acquisition. 
   
2.2.3.2. Preparation and perfusion of the rat hearts 
The use of rats was registered at the JLU Giessen (472_M). Rat hearts were used for 
Langendorff experiments. 
Rats were bred and raised in the animal facility of the Institute of Physiology, Justus Liebig 
University. Animal nutrition (standard diet: Altromin®) and water were given ad libitum. 
At the start, 3-month-old female Wistar-Hannover rats with a weight of 240 g ± 20 g were put into 
a Plexiglas chamber and shortly thereafter were anesthetized by isoflurane. Muscle tone and 
corneal reflex were checked and after verifying that the reflex activity was lost, they were 
sacrificed by a cervical dislocation. Afterwards, the abdomen was opened, the heart together 
with the attached organs were excised from the animal’s body and immediately were immersed 
in a petri dish filled with 4°C cold sodium chloride. Cold sodium chloride is used to prevent any 
ischemic injury during the time interval between removal of the heart from the animal and 
perfusion in the Langendorff system.  
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Using tweezers the surplus organs like esophagus, trachea, and thymus were cut away from the 
heart. Perfusate was permitted to slowly drop from the cannula before cannulation for the reason 
that this aids to remove any air bubble during the insertion of the heart to cannula. 
Then, through the opened aortic root, heart was held with forceps to the cannula (perfusion 
cannula is made of stainless steel with inner diameter 1.8mm and the external diameter 3.0mm) 
in the chamber of the Langendorff apparatus and finally it was fixed with a surgical thread Nr. 40. 
The cannula is connected to the reservoir of nutrient rich, oxygenated solution named Krebs-
Henseleit buffer (Table 11). It is steadily gassed with Carbogen® gas mixture containing 5% CO2 
and 95% O2. The perfusion fluid was allowed to flow thoroughly since the heart was securely 
attached to the cannula. Finally, an intraventricular latex balloon (size 5) was inserted to assess 
the contractile activity of the heart. The deflated balloon was linked to a rigid catheter and 
pressure transducer. It was inflated with water until the diastolic pressure ranged from 5-8 
mmHg. As soon as the balloon was fixed, parameters like left ventricular systolic pressure 
(LVSP), left ventricular end diastolic pressure (LVEDP), and heart rate (HR) could be measured 
and documented. Having these parameters recorded helped to calculate the left ventricular 
developed pressure (LVDP) and coronary vascular resistance (CVR). 
Table 11. Krebs-Henseleit Buffer (pH 7.4) 
Substance Molarity (mM) Concentration (g/L) 
NaCl 140 8.18 
KCl 2.7 0.20 
NaH2PO4 x H2O 0.4 0.055 
MgCl2 x 6H2O 1.0 0.2 
Glucose 5.0 0.99 
CaCl2 x 2H2O 1.8 0.26 
NaHCO3 24 2.02 
Experiments run at the constant flow. In the first 20 minutes, a stabilization phase took place 
before treatment, where the flow rate was held constant between 7-10 ml/min. Aortic pressure 
was arranged from 41-50 mmHg and the diastolic pressure 10-12 mmHg. After this period, mean 
LVDP was 987 mmHg (37oC) and 1245 mmHg (32oC; p=0.007 vs. 37oC). For 20 min 
stabilization period the cardiac functions were re-established, then the perfusion phase followed 
for 120 min. Every 15 min the heart rate was recorded, the values ranged between 170-250 
beats/min. 
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Experiments were divided into two sections, each of them performed using Krebs-Henseleit 
Buffer (pH 7.4) but at different temperatures. A set of rat hearts was perfused at 37°C and the 
other one at 32°C. The experiments were carried out in the chamber of the Langendorff system 
where two rat hearts were hanged, one of them being perfused with Krebs-Henseleit Buffer 
mixed with LPS (1 mg/ml), and the other one with Krebs-Henseleit Buffer only, for two hours. At 
the end of perfusion phase PTHrP (1-34) (100 nmol/L) was added to the perfusion buffer for 10 
min as seen in Fig. 6. The same protocol was applied for the perfusion of rat hearts in the 
Langendorff system, except temperature change for two sets of experiments, namely 37°C and 
32°C. LVDP was recorded after 120 min LPS administration (1 mg/ml). Whereas, PTHrP 
responsiveness was determined according to the changes observed in LVDP after 
administration of PTHrP(1-34) (100 nmol/L) to the perfusate for 10 min.  
 
 
Figure 6. Perfusion flow of rat hearts in the Langendorff system 
 
2.2.3.3. Isolation of rat ventricular myocytes  
As mentioned before the use of rats was registered at the JLU Giessen (472_M). Animals were 
fed with standard diet Altromin® and water. Both were given ad libitum. They were bred and 
raised in the animal facility of the Institute of Physiology, Justus Liebig University. 
Ventricular cardiomyocytes were isolated from 3-4-month-old male Wistar rats with a weight of 
300-400 g. Initially, the animal was put into a Plexiglas chamber and anesthetized by isoflurane. 
After it lost the reflex activity, the thorax was opened by cervical dislocation and the heart was 
removed from the animal. It was immediately put into the ice-cold saline (9 g/l NaCl) in the Petri 
dish. Remnant tissue organs adjacent to the heart were removed and finally the heart was 
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mounted on the Langendorff perfusion system. Firstly, for 3-5 min at 10 ml/min the heart was 
perfused with perfusion buffer (Table 12) to get rid of blood on the organ.   
Table 12. Perfusion Buffer (Powell Medium) (pH 7.4, gassed with 95% O2/ 5% CO2) 
Perfusion Buffer Molarity (mM) 
NaCl 110 
KCl 2.5 
KH2PO4 1.2 
MgSO4 x 7H2O 1.2 
Hepes  25 
Glucose 11 
 
Then collagenase was added to the buffer and perfusion was continued for further 25 min. 
Thereafter, the heart was disconnected from the Langendorff perfusion system, ventricles were 
cut from the rest of the heart and minced. The cell suspension was incubated for 5 min in a 
beaker filled with collagenase buffer. Carbogen (5% CO2/ 95% O2) was added to the cell 
suspension for 5 min and the solution was mixed through a pipette, which facilitated the release 
of cells from tissue pieces, namely the digestion. Using a 200 μm nylon mesh the cell 
suspension was filtered and then centrifuged shortly for 3 min at 25 g. The pellet containing 
cardiomyocytes was resuspended in buffer solution, and at this point 0.2% (v/v) calcium stock 
solution (100 mmol/L CaCl2 in H2O) was added to the medium (final concentration 200 μmol/L). 
Finally, 2-3 ml of the cell suspension was added to 12 ml bovine serum albumin gradient (BSA 
gradient contains 4% BSA (w/v), 1% calcium stock solution in perfusion buffer) and solution was 
centrifuged for 1 min at 15 g. Afterwards, the pellet with rod shaped cardiac myocytes was 
suspended in 25 ml CCT medium. 
To culture cardiomyocytes firstly the media required for plating and washing the cells were 
prepared a day before starting the cell isolation procedure. Culture dishes were prepared by 
adding 1 ml of plating medium to each cell culture dish and stored in the incubator at 37°C. The 
washing medium was stored in the 4°C fridge overnight. However, hours before use it was 
placed in the water bath at 37°C. 
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Table 13. Cell culture media 
Plating medium Washing Medium CCT Medium 
Basal culture medium (CCT) Basal culture medium (CCT) Medium 199 
FCS 4% (vol/vol) Penicillin/Streptomycin 2% Creatine 5 mmol/l; carnitine 
2 mmol/l; taurine 5 mmol/l; 
cytosine-β-
arabinofuranoside 10 
μg/ml; penicillin 100 IU/ml; 
streptomycin 100 μg/ml 
Penicillin/Streptomycin 2%  
After isolation of cardiomyocytes, the cell culture dishes stored in the incubator overnight were 
taken out and the preincubation solution (plating medium) was removed. 1 ml of the cell 
suspension was plated to each culture dish and stored in the incubator at 37°C for 1-2 hours. 
Afterwards, cell culture dishes were washed with washing medium (see Table 13) in order to 
remove round and nonattached cells. LPS 10 μg/ml and PTHrP (7-34) 10 μM were added to 
particular dishes and all together were stored in the incubator at either 37°C or 32°C for the 
following cell contraction procedure.  
 
2.2.3.4. Measurement of cell shortening 
Ventricular myocytes represent the cardiac contractile unit. The technique used to assess the 
ventricular contractile function is the edge-detection system. This method provides information 
about changes in myocyte length.  
Rod-shaped myocytes with regular contraction and clear edges were used for assessment. The 
cell being analyzed is shown via a line-camera on the computer monitor. Cell stimulation was 
applied with 50 V, 5 msec duration using two AgCl electrodes with biphasic electrical stimuli 
made up of a pair of wires placed in an opposite way. Cells were exposed to LPS (1 mg/ml) at 
32oC or 37oC for 2 h and paced at a frequency of 2 Hz in the presence or absence of the 
receptor antagonist PTHrP (7-34) (100 nmol/l).. The contraction of an individual cell was 
measured every 15 sec four times, the median was calculated and this was used as the average 
of cell shortening of the particular cell. Nine cells were analyzed pro culture dish, for a particular 
condition, three plates were prepared. In total two sets of preparations were analyzed. Data are 
expressed as percentage of systolic cell length relative to diastolic cell length (dl l-1 (%)).  
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2.2.4. Quantitative real time PCR 
2.2.4.1. RNA isolation 
Tissue samples were put in the tubes with bulk beads, 1ml PeqGold Trifast™ reagent (Trizol) 
was added to each tube, and thereafter samples were homogenized in Precellys® 24 Bead Mill 
Homogenizer using the program 3 with these features: 6000 rpm, 2 times 20 seconds. Then, 
100 μl chloroform was added to each tube and mixed in vortex till the mixture was milky. 
Subsequently tissue samples were centrifuged for 15 min, at 4°C, at 12.500 rpm and this led to 
formation of three phases in the tube. The upper phase contains the RNA which was taken with 
pipette and put into 1.5 ml tubes. The amount of RNA in the tube was mixed in 1:1 proportion 
with isopropanol. The tubes with bulk beads containing the lower two phases were thrown away 
in P/C waste. 
Tubes containing the RNA and isopropanol were mixed in vortex and thereafter stored in the 
fridge at -20°C for 1 hour or overnight. After that tubes were centrifuged for 15 min, at 4°C, at 
12.500 rpm. The supernatant was taken out with pipette and discarded in P/C waste. Whereas 
the pellet wax mixed with 1ml ethanol 70%, vortexed and put in the centrifuge for further 15 min, 
at 4°C, at 12.500 rpm. Ethanol was discarded after centrifugation and the tubes with RNA were 
left for one hour to dry. And finally, an amount of water was added to the RNA containing tubes, 
according to the tissue sample 20 μl for lung and 50 μl for left ventricle tissue. Tubes were 
shortly vortexed and stored on ice in the fridge (4°C) for one hour and thereafter for long-term 
storing in the -80°C fridge. 
 
2.2.4.2. Determination of RNA concentration 
NanoDrop® ND-1000 Spectrophotometer was used to determine the concentration of RNA. 
Samples were kept on ice during the whole process. Initially the blank sample containing only 
aqua bidestilata was measured, continuing with other tissue samples. 1.5 μl tissue sample was 
quickly given to the sensor and measured. The value coming out from the measurement should 
be between 200-2500 ng/μl. If the sample was more concentrated, then a.b. was used to dilute 
the sample until its concentration became between the values aforementioned. In case the 
sample was lung or left ventricle 20 μl or 50 μl respectively was added to the previously 
measured sample. The amount of RNA was calculated in following way: 
(1000/Value after dilution)*1 = X (RNA amount taken from the sample) →5 μl - X = Y (a.b.) 
The amount of RNA (X) and a.d. (Y) were mixed in a tube, vortexed, and proceeded with cDNA 
synthesis. 
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2.2.4.3. cDNA synthesis 
Before starting the procedure the bench-tops, pipettes, plasticware and everything needed for 
cDNA synthesis were cleaned with RNase AWAY™ in order to eliminate the RNase and DNA 
from the laboratory surfaces. 
Tissue samples were kept on ice, vortexed and thereafter put into the thermocycler. Using 
Program 1 samples remained for 15 minutes at 60°C in the thermocycler for denaturation of the 
single stranded mRNA.  
In the meantime, the reaction mix was prepared as follows: 
5xRT-Buffer (2 μl/sample) 
Oligo dt (1 μl/sample) 
dNTP’s (1 μl/sample)→ Deoxynucleoside triphosphates (dGTP, dTTP, dCTP, dATP).  
DTT (0.5 μl/sample) 
RNAsin (0.2 μl/sample) 
Every component was added in a 2 ml tube, mixed and finally M-MLV-RT (0.3 μl/sample) was 
added but not vortexed any longer. 
After 15 min. tubes containing mRNA and a.d. were taken out of thermocycler and the reaction 
mix was added in 1:1 proportion. Mixture was vortexed and tubes were put in the thermocycler. 
Using the program 3, incubation carried out for 60 min at 37°C. Subsequently it proceeded with 
inactivation of the reverse transcriptase for 5min at 95°C. The obtained cDNA was diluted with 
a.b. in 1:10 proportion and stored in -20°C fridge for qPCR experiments. 
 
2.2.4.4. Quantitative real time PCR (qPCR)  
cDNA samples diluted in proportion 1:10 were used for qPCR. 3 μl of sample was put in PCR-
tubes. Each sample was applied in duplicate.  
Thereafter the PCR-Mix for one tube was prepared as follows: 
10 μl SYBR Green Mix                  
0.6 μl Primer (forward + reverse)    
6.4 μl Aqua Bidest. 
Forward and reverse primers were mixed in 1:1 proportion and this mixture was diluted with a.b. 
in 1:10 proportion. 
Plate was initially designed according to the samples.  
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3 μl cDNA sample and 17 μl PCR-Mix were put into the PCR tubes. 3 μl of a.b. and Mix were put 
in the first two tubes and named as „Mix”. Prepared samples were put in the iCycler, exactly in 
the same positions as appointed in the plate. Primer temperature was set, and PCR was run. 
The procedure of PCR in the iCycler comprises 20-50 cycles. These are temperature changes 
repeating throughout the process: 
1.  Cycle (1x):    Initialization for 15 minutes at 95°C (enzyme activation step) 
2. Cycle (45x):   Denaturation for 30 seconds at 95°C (this step implicates the disruption of 
the DNA template and formation of single-stranded DNA molecules) 
                                  Annealing for 30 seconds at x°C (annealing of the forward and reverse    
primers to the single-stranded DNA molecules) 
                                   Elongation for 30 seconds at 72°C (at the extension/elongation step a new   
DNA strand complimentary to the DNA template is created. This is done by DNA polymerase 
which adds dNTP’s in 5' to 3' direction) 
3. Cycle (100x): Melting curve for 10 seconds at 50°C 
 
An invariant endogenous control (reference gene), a so-called housekeeping gene was used to 
normalize the data obtained in quantitative RT-PCR experiments. Data regarding mouse and rat 
samples were normalized to Hypoxanthine Phosphoribosyltransferase (HPRT) expression. β2 
microglobulin (B2M) was used as an alternative housekeeping gene, but it showed high 
variability between samples. Therefore, results are represented according to HPRT 
normalization. While pig samples were normalized to Glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH). The procedure includes dividing of the measured relative abundance 
value for each target gene sample by the amount of the housekeeping gene in the 
corresponding sample. After normalization, different sample groups can be compared. 
 
 
2.2.4.5. Statistics 
Data obtained from quantitative qPCR are presented as means  S.D. or box plots. The results 
between groups were compared by two-side ANOVA and Student-Newmann-Keuls post hoc 
analysis. To assess the normal distribution of the samples Levene’s test was performed. A p-
value of 0.05 implied a statistically significant result. 
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2.2.5. Western Blotting  
2.2.5.1. Preparation of lysate from tissue 
The tissue samples to run on a gel firstly need to be lysed in order to release the protein of 
interest. The lysis buffer enables the cell membrane to disrupt and solubilizes the intracellular 
proteins. Thus, proteins can move separately through the gel. The following table includes the 
components of the lysis buffer used for tissue sample preparation.  
Table 14. 10X Lysis Buffer 
Reagents 
Tris-HCl (pH 7,5)                 20 mM 
NaCl                                    150 mM 
Na2EDTA                             1 mM 
EGTA                                   1 mM 
Triton                                    1% 
Sodium Phosphate               2.5 mM 
β- glycerophosphate            1 mM 
Na3VO4                                                   1 mM 
Leupeptin                             1 μg/ml 
 
10X lysis buffer were then diluted in 1:10 proportion with a.b. and afterwards 200 μl of a serine 
protease inhibitor 0.1 M PMSF (phenylmethylsulfonyl fluoride) was added. 
The frozen tissue samples were left to thaw in room temperature and then 0.1 g from each 
sample was mixed with 500 μl lysis buffer in tubes with bulk beads. Subsequently the samples 
were homogenized in Precellys24 for 2x20 seconds at 6000 rpm.  
After homogenization, samples were kept on ice for 5-10 minutes. Then ultrasonic treatment was 
applied to each sample for 30-60 seconds in order to unfold more the proteins and reduce the 
intermolecular interactions. 
These sample suspensions were centrifuged for 10 min. at 4°C, at 14.000 rcf. The supernatant 
was taken into 1.5 ml tubes. 20 μl of sample from each tube was taken into new tubes and 
diluted with 380 μl a.b. (1:20 proportion). Finally, 100 μl from the latter tubes were mixed with 40-
μl Laemmli buffer (Table 15) and boiled for 5 min at 95°C in thermoblock. 
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Table 15. Sample Buffer, Laemmli 2x Concentrate (pH 6.8) 
Components 
SDS                                       0.2 g 
Dithiotreitol                            0.154 g 
Glycerin (100%)                    2.0 ml 
BPB                                       0,2 ml 
Tris                                        0.5 M 
Aqua Bidestillata                   1.8 ml 
 
The SDS detergent is used to denature the proteins. The bromophenol blue is a dye, which 
moves before proteins and enables to see the sample throughout loading. The glycerol is used 
to increase the sample density that facilitates the sample to stay in the sample well. 
 
2.2.5.2. Loading the samples and running the gel 
The XCell SureLock™ Mini-Cell system was used to carry out the SDS-Polyacrylamide Gel 
Electrophoresis (SDS-PAGE). 10% NuPAGE® Bis-Tris mini-gels were used to separate small to 
medium-sized proteins during gel electrophoresis. 1x MOPS SDS running buffer was prepared 
(50 ml 20x MOPS running buffer + 950 ml a.b.) for use in the next steps. 2 gel cassettes initially 
were washed with a.b., the lower part of the cassette with 1x MOPS running buffer and then 
inserted into the lower buffer chamber. The upper buffer chamber (cathode) was filled with 200 
ml 1x MOPS running buffer and 500 μl antioxidant. The sample wells were washed with 1x 
MOPS running buffer using a syringe and a cannula.  
Samples were boiled once more for 5 min at 95°C in the thermoblock, shortly centrifuged and 
vortexed. 20 μl of sample was used for gels with 10 wells, whereas 10-15 μl sample for gels with 
15 wells depending on the number of samples.  
The Hamilton syringe was used to underlay the samples into the gel wells. The molecular weight 
marker was put via syringe into the first well, tissue samples in other wells. 
The lower buffer chamber (anode) was filled with 600 μl 1x MOPS running buffer and afterwards 
the lid was properly closed and electrode cords were connected to the power supply so that the 
red one to + jack and the black one to – jack. The power was turned on and the run was 
conducted for 50 min. at 200 V.   
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2.2.5.3. Wet electroblotting (Wet transfer) 
At the time, while electrophoresis of the gels was in progress the materials and the buffer 
needed for transfer were prepared. For blotting NuPAGE® gels, the following buffer was 
prepared: 
Table 16. Transfer Buffer 
Reagent Amount 
NuPAGE® Transfer Buffer (20x) 25 ml 
NuPAGE® Antioxidant 500 μl 
Methanol 20% 100 ml 
Deionized Water 375 ml 
 
4 filter paper (9 x 7.5 cm), 2 membranes (nitrocellulose), and 5 sponges were used for 
transferring the protein from the gel to membrane.  
40 ml of buffer was used for transfer in the mini-cell unit. 10 ml was used to rinse the 
membranes before preparing the sandwich. 10 ml to soak the filter papers briefly before using 
and the rest was used for the sponges.  
The gel/membrane sandwich was prepared according to the manufacturer’s instructions 
(sponge-filter paper-gel-transfer membrane-filter paper-sponge). This gel sandwich was placed 
in the mini-cell unit and the tank filled with 40ml transfer buffer (until the sandwich is covered 
with buffer). The run was carried out at 30 V for 1 hour.  
 
2.2.5.4. Antibody incubation 
After the electrotransfer the nitrocellulose membrane was washed 2-3 times with distilled water 
and thereafter the membrane was blocked for 1 hour at room temperature on a shaker using 5% 
BSA in 1xTBS buffer.   
Table 17. 10xTBS Buffer (pH 7.4) 
Reagent Molarity 
Tris/HCl 10 mM 
NaCl 150 mM 
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First antibody was added in 5% BSA and TBS buffer solution and the membrane incubated 
overnight at 4°C on a shaker. In the case where the membrane was incubated with the loading 
control (actin), 0.1% Tween20 was added to the incubating solution. Afterwards the membrane 
was washed in TBST buffer (1xTBS buffer + 0.1% Tween20) 2-3 times, 10 min each washing on 
the shaker at room temperature.  
The enzyme conjugated (horseradish peroxidase) secondary antibody was prepared in 5% BSA 
and TBST solution in appropriate proportion and added to the membrane, incubated at room 
temperature for 1 hour on the shaker. 
After one hour the membrane was washed 2 times with TBST solution and once with 1xTBS 
buffer, 10 min each washing. The last washing was applied with TBS buffer without Tween20 to 
reduce the high background, a problem caused by Tween20 interfering with the ECL solution, 
used in the following step. 
 
2.2.5.5. Enhanced chemiluminescence (ECL) Detection 
ECL is a method used to acquire image of the membrane following the western blot protocol. In 
the darkroom, firstly, the chemiluminescence reagents namely peroxide and enhancer solutions 
were mixed in a dish, 4 ml each. This solution was poured into a dish with the membrane and 
incubated at room temperature for 2 min. 
Then membrane was placed on a glass plate inside the ECL device and the result visualized 
according to the exposure time recommendations given by the instrument. 
Quantity One is the program used to accomplish the evaluation of western blot analysis. Actin 
was used as loading control in performed western blot experiments. 
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3. Results  
3.1. Pulmonary expression of PTHrP in mice  
3.1.1. Effect of high fat diet on pulmonary expression of PTHrP in adult mice   
Mice fed with HFD in comparison with those fed with ND gain weight from 35.8  0.9 g to 46.7  
0.8 g and plasma leptin levels elevated from 4.95  0.83 ng/ml to 15.91  2.41 ng/ml (each 
p<0.001, n=6-8). As shown in Fig. 7A, PTHrP mRNA expression in the lung of control mice fed 
with HFD increased significantly. 45 min ischemia and four weeks reperfusion elevated the 
pulmonary mRNA expression of PTHrP in adult mice independently of diet. HFD seemed not to 
affect significantly the PTHrP expression in the lung when mice experience ischemia/reperfusion 
(Fig 7A). 
Fig. 7B displays the pulmonary mRNA expression of PTH-1R. It is obvious in the figure that it 
increased in the sham HFD mice whereas in mice subjected to ischemia/reperfusion was stable, 
no matter if they were fed with normal or high fat diet. 
ADRP and PPARγ expression was analyzed as PTHrP downstream targets in the lung to 
analyze receptor activity. As shown in Fig. 7C and 7D, HFD increased their mRNA expression in 
sham mice. PTHrP and ADRP mRNA expression seemed to be strongly correlated. Pulmonary 
mRNA expression of PPARγ increased significantly in ischemia/reperfusion HFD mice (Fig. 7D). 
The data suggest that leptin could play a pivotal role in regulating the pulmonary expression of 
PTHrP system under basal conditions. 
Therefore, leptin deficient mice (ob mice) were used to prove the significance of leptin in this 
process (data not shown). Ob-mice increased body weight (50.5 ± 3.8 g vs. 26.0 ± 3.2 g, n = 4, p 
< 0.001). Experiments showed a significant decrease in mRNA expression of PTHrP in this mice 
model. The decrease in pulmonary expression of PTHrP did not cause the subsequent decrease 
in the mRNA expression of PTH-1R or the downstream targets ADRP and PPARγ. Therefore, 
the data indicate that leptin induces the pulmonary PTHrP expression and the downstream 
targets in mice fed with HFD only in case it is activated. 
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Figure 7. Pulmonary mRNA expression of PTHrP, PTH-1R, ADRP, and PPARγ in seven months old 
mice fed with either normal diet or high fat diet and subjected to either sham surgery or 
ischemia/reperfusion. The first bar (white) shows the group of mice fed with normal diet and subjected to 
sham surgery (ND-Sham, n=12); the second bar (blue) shows mice fed with high fat diet which underwent 
sham surgery (HFD-Sham, n=7); the third bar (red) indicates the group of mice fed with normal diet which 
underwent ischemia/reperfusion (ND-I/R, n=9); and the fourth bar (black) indicates the mice fed with high 
fat diet which underwent ischemia/reperfusion (HFD-I/R, n=10). Data are expressed as box plots. The 
dashed line indicates the mean expression level of ND-Sham. *, p<0.05 vs. ND-Sham. 
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3.1.2. Effect of high fat diet on pulmonary expression of PTHrP in older mice 
The impact of ageing, high fat diet, and ischemia/reperfusion on the expression of PTHrP and its 
downstream targets was analyzed in the lungs of 13-month-old mice. 
Fig. 8 shows no differences between the groups compared, except for PPARγ. PTHrP mRNA 
expression was higher in older mice (Fig. 8A, white bar) compared to adult ones when mice 
were fed with ND and experienced no treatment (Fig. 7A). However, no significant differences 
were observed, neither in the case when mice were fed with HFD nor when they underwent 
ischemia/reperfusion protocol. mRNA expression of PTH-1R and ADRP showed similar results 
with no significant differences (Fig. 8B and 8C, respectively). Pulmonary expression of PPARγ 
displayed in Fig. 8D indicates a significant increase in HFD group of mice subjected to 
ischemia/reperfusion compared to sham group fed with ND.  
Finally, the observed results suggest that pulmonary expression of PTHrP is age-dependent 
being up regulated in older mice. However, the induction of PTHrP expression in the lungs of 
older mice does not activate the entire PTHrP system. HFD and ischemia/reperfusion did not 
have a remarkable effect in these mice.  
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Figure 8. Pulmonary mRNA expression of PTHrP, PTH-1R, ADRP, and PPARγ in thirteen-month-old 
mice fed with either normal diet or high fat diet and subjected to either sham surgery or 
ischemia/reperfusion. The first bar (white) displays the group of mice fed with normal diet and subjected to 
sham surgery (ND-Sham, n=6); the second bar (blue) shows mice fed with high fat diet which underwent 
sham surgery (HFD-Sham, n=5); the third bar (red) indicates the group of mice fed with normal diet which 
underwent ischemia/reperfusion (ND-I/R, n=8); and the fourth bar (black) indicates the mice fed with high 
fat diet which underwent ischemia/reperfusion (HFD-I/R, n=6). Data are expressed as box plots. The 
dashed line indicated the mean expression level of ND-Sham. *, p<0.05 vs. ND-Sham. 
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3.1.3. Effect of HFD, ageing, and ischemia/reperfusion on PTHrP and PTH-1R 
expression 
Ageing, ischemia/reperfusion, and HFD are conditions which animals were subjected to. The 
data observed by now recommended that these conditions have an influence on PTHrP 
expression. A high induction of PTHrP was detected under all aforementioned conditions. 
Further experiments were performed in order to verify if there is the same impact on protein 
expression of PTHrP and PTH-1R.  
Fig. 9A and 9B display the protein expression of PTHrP where it is obvious a high increase of 
pulmonary PTHrP protein in adult mice undergoing ischemia/reperfusion. HFD seemed to have 
no additive impact on PTHrP protein. Apparently, expression of PTHrP protein was not 
significantly elevated in the steady state, which implies a high pulmonary PTHrP turnover under 
stress conditions.  
As for the protein expression of PTH-1R, it was significantly increased only in mice fed with HFD 
and thereafter subjected to ischemia/reperfusion (Fig. 9A and 9C).  
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Figure 9. Pulmonary protein expression of PTHrP and the corresponding PTH-1R in seven months 
old mice. A) Representative western blot; B) Mean protein expression of PTHrP; C) Mean protein 
expression of PTH-1R. Data are expressed as box plots. The dashed line indicates the mean expression 
level of ND-Sham. *, p<0.05 vs. ND-Sham.  
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Experiments carried out in old mice (Fig. 10) revealed no significant differences between the 
groups compared.  
 
 
 
Figure 10. Pulmonary protein expression of PTHrP and the PTH-1R in thirteen months old mice. A) 
Representative western blot; B) Mean protein expression of PTHrP; C) Mean protein expression of PTH-
1R. Data are expressed as box plots. The dashed line indicates the mean expression level of ND-Sham.   
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3.1.4. Effect of high fat diet on pulmonary elastin expression 
The mRNA expression of PTHrP and the downstream targets ADRP and PPARγ was 
upregulated in mice fed with high fat diet. This indicates an activation of the paracrine pathway 
under high fat diet conditions. Activation of this paracrine loop implies the stimulation of 
surfactant production and lung function. However, pulmonary function depends on lung elasticity 
as well, which is determined by extracellular matrix proteins. Therefore, pulmonary elastin 
expression was checked in order to analyze this special feature. 
Experiments conducted in adult mice revealed no significant differences between groups (Fig. 
11A). Whereas in older mice (Fig. 11B) the mean elastin expression was reduced significantly in 
sham mice fed with standard diet. 
Results indicate that the induction of surfactant production by PTHrP paracrine pathway is 
selectively activated by high fat diet.  
 
 
Figure 11. Pulmonary mRNA expression of elastin in seven (A) or thirteen (B) months old mice. 
Data are expressed as box plots. The dashed line indicates the mean expression level of ND-Sham.  
*, p<0.05 vs. ND-Sham.  
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3.2. Effect of HT and LPS on PTHrP receptor responsiveness in vivo 
3.2.1. Role of inflammatory cytokines in LPS induced sepsis 
As mentioned before, chemokines, cytokines, and other inflammatory regulators are released 
following the feedback of the innate immune response toward pathogenic microorganisms or 
toxins invaded into the blood circulation as a result of sepsis, we analyzed one of pro-
inflammatory cytokines, down-stream target of NFκB termed monocyte chemoattractant protein-
1 (MCP-1). 
The expression of pro-inflammatory cytokine MCP-1 was analyzed in the lung, left ventricle of 
the heart, liver, and aorta under both temperature conditions. As shown in Fig.12. LPS 
administration increased the mRNA expression of MCP-1 in all tissues under investigation. Liver 
(Fig.12C) is an exception where LPS did increase the mRNA expression of MCP-1 under both 
temperature conditions in comparison with sham group. Nevertheless, decreasing the 
temperature did not have any significant impact on the mRNA of MCP-1 compared to other 
tissues. In lung (Fig.12A), left ventricle (Fig.12B), and aorta (Fig.12D) tissues, decrease in 
temperature (33°C) elevated more the MCP-1 mRNA compared to normothermic pigs. However, 
there is an increase in both cases independently of temperature compared to the control group, 
which neither received LPS nor was assigned to temperature change. Results corroborate no 
impact of temperature on proinflammatory effects of LPS. 
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Figure 12. mRNA expression of MCP-1 in different tissues after LPS-treatment. (A) lung, (B) left 
ventricle, (C) liver, and (D) aorta. White bar indicates sham animals. Blue bar indicates normothermic 
animals (NT=38°C) that received LPS. Red bar indicates animals that received LPS and assigned to mild 
hypothermia (HT=33°C). Data are expressed as means  S.E.M. from n=6-7 samples. p<0.05 vs. Sham.  
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3.2.2. Role of hypothermia in PTHrP expression in the lungs of septic pigs 
PTHrP plays an important role in lung development and function. The aim of investigation was to 
find out changes in mRNA and protein expression of PTHrP and downstream targets under 
sepsis conditions and temperature alteration. 
Fig. 13A displays the PTHrP mRNA expression in lung, where the white bar shows the PTHrP 
mRNA (control) being not influenced neither from bacterial endotoxin, nor from temperature 
decrease. Pigs given LPS showed significant increase in PTHrP mRNA (marked with blue bar) 
compared to control. Red bar shows an increase in mRNA expression of PTHrP in the group of 
pigs that received LPS and the temperature was reduced to 33°C. Endotoxin elevated the 
PTHrP expression in the lung but temperature did not have any significant impact.  
PTH-1R mRNA shown in Fig. 13B decreased after the LPS administration independently of 
temperature.  
 
 
Figure 13. Pulmonary mRNA expression of PTHrP (A) and PTH-1R (B) in the lungs of septic pigs. 
White bar indicates sham animals. Blue bar marked indicates normothermic animals (NT=38°C) that 
received LPS. Red bar indicates animals that received LPS and assigned to mild hypothermia (HT 
=33°C). Data are expressed as means  S.E.M. from n=6-7 samples. p<0.05 vs. Sham. 
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As for protein expression of PTHrP shown in Fig. 14A and 14C there was an obvious increase 
after the LPS administration compared to sham animals, indicating that induction of PTHrP 
protein is caused by transcriptional activation. However, no significant difference was observed, 
neither in case when temperature was kept normal (38°C) nor decreased to 33°C. 
In contrast, protein expression of PTH-1R remained stable independently of temperature and 
LPS administration (Fig. 14B and 14D). The inverse correlation between mRNA and protein 
expression of PTH-1R indicates that the decrease in mRNA expression of the receptor might not 
have impact on its protein expression because the half-life of the receptor may be too long. 
 
 
Figure 14. Effect of LPS on protein expression of PTHrP and PTH-1R in the lung. Representative 
western blots (A) and (B), respectively; mean protein expression (C) and (D), respectively. Data are 
expressed as means  S.E.M. from n=6-7 samples. White bar indicates sham animals. Blue bar indicates 
normothermic animals (NT=38°C) that received LPS. Red bar indicates animals that received LPS and 
assigned to mild hypothermia (HT=33°C). p<0.05 vs. Sham.  
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One of pulmonary PTHrP downstream targets expressed in lung lipofibroblasts and presumably 
involved in lipid storage and transfer, namely ADRP was analyzed (Fig 15A). ADRP mRNA 
increased noticeably in the lungs of septic pigs, indicating an activation of the PTHrP system in 
the lung. Mild hypothermia seemed to decrease the ADRP mRNA expression compared to 
normothermia.  
The mRNA expression of an anti-apoptotic protein Bcl-2 (B-cell lymphoma 2) was investigated, 
which, is believed to be important for survival and function of lymphocytes. Apparently, 
endotoxin did not alter significantly the mRNA expression of Bcl-2 (Fig. 15B). Keeping the 
temperature constant or decrease had not impact on the expression of Bcl-2.  
Finally, data regarding pulmonary expression of PTHrP and downstream genes suggest an 
induction in the PTHrP system under septic conditions but hypothermia did not have any 
significant impact on analyzed pulmonary parameters.  
 
 
Figure 15. Effect of LPS on pulmonary mRNA expression of PTHrP downstream targets, ADRP (A) 
and Bcl-2 (B). Data are expressed as means  S.E.M. from n=6-7 samples. White bar indicates sham 
animals. Blue bar indicates normothermic animals (NT=38°C) that received LPS. Red bar indicates 
animals that received LPS and assigned to mild hypothermia (HT=33°C). p<0.05 vs. Sham.  
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3.2.3. Effect of hypothermia and endotoxin on PTHrP system in the liver 
Liver is one of vital organs known to fail as a consequence of septic shock. PTHrP is known to 
be induced in vital organs under septic conditions. The aim was to analyse if temperature 
change could modify the situation. Administration of LPS elevated considerably the PTHrP 
mRNA levels (Fig. 16A). Mild hypothermia displayed with red bar in the figure, increased the 
PTHrP expression towards normothermia. Thereby, endotoxin and even temperature change did 
affect the PTHrP levels in the liver.  
Regarding PTH-1R shown in Fig. 16B, as found in the lung tissue, LPS decreased its mRNA 
expression in a temperature dependent way.  
 
Figure 16. mRNA expression of PTHrP (A) and PTH-1R (B) in the liver of septic pigs. Data are 
expressed as means  S.E.M. from n=6-7 samples. White bar indicates sham animals. Blue bar indicates 
normothermic animals (NT=38°C) that received LPS. Red bar indicates animals that received LPS and 
assigned to mild hypothermia (HT=33°C). p<0.05 vs. Sham.   
 
Protein expression of PTHrP in liver (Fig. 17A and 17C) is higher in control animals than after 
giving the LPS. As shown with blue and red bars, temperature did not influence significantly the 
protein expression.  
On the other hand, protein expression of PTH-1R is as high as PTHrP protein and neither LPS 
administration nor temperature change did alter the expression of the receptor.  
Fig. 17B shows no difference between the loading control β-Actin and PTH-1R, in the same way 
like bars in Fig. 17D. 
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Figure 17. Effect of LPS on protein expression of PTHrP and PTH-1R in the liver. Representative 
western blots (A) and (B), respectively; mean protein expression (C) and (D), respectively. Data are 
expressed as means  S.E.M. from n=6-7 samples. White bar indicates sham animals. Blue bar indicates 
normothermic animals (NT=38°C) that received LPS. Red bar indicates animals that received LPS and 
assigned to mild hypothermia (HT=33°C). p<0.05 vs. Sham.  
Liver response to LPS and most importantly the role of temperature change were checked 
through the expression pattern of an important regulator of the immune system and profibrotic 
protein, the cytokine transforming growth factor ß1 (TGF-ß1). Sepsis, as expected elevated the 
cytokine levels under normothermic conditions, as shown in Fig. 18A, blue bar. Hypothermia 
reduced the TGF-ß1 mRNA levels compared to normothermia.  
The mRNA expression of profibrotic protein Collagen-1 was quantified in the liver of septic pigs 
and during the temperature alteration (Fig 18B). When temperature was kept normal (38°C), 
LPS administration up regulated the expression of COL1A1, whereas hypothermia decreased its 
mRNA expression. As shown in the figure below there is a correlation between the mRNA 
expression of TGF-ß1 and alpha-1 type I collagen (COL1A1) in the liver. However, the results 
revealed no significant effect of endotoxin and hypothermia on the expression of these 
profibrotic proteins. Therefore, data reveal a little proof that PTHrP system in the liver might have 
any functional relevant activation.  
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Figure 18. Effect of LPS on mRNA expression of PTHrP downstream targets, TGF-ß1 (A) and 
Collagen-1 (B) in the liver. Data are expressed as means  S.E.M. from n=6-7 samples. White bar 
indicates sham animals. Blue bar indicates normothermic animals (NT=38°C) that received LPS. Red bar 
indicates animals that received LPS and assigned to mild hypothermia (HT=33°C). p<0.05 vs. Sham.  
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3.2.4. Effect of LPS and hypothermia on PTHrP system in the left ventricle 
Left ventricle of the heart was used to investigate the role of LPS and hypothermia in the cardiac 
expression of PTHrP. LPS appeared to downregulate the mRNA expression of PTHrP and PTH-
1R in a temperature dependent way, as shown in Fig. 19A and 19B respectively.  
Findings in the left ventricle are the opposite to other tissue organs investigated so far, where 
LPS steadily increased the mRNA expression of PTHrP. 
 
Figure 19. Effect of LPS on mRNA expression of PTHrP (A) and PTH-1R (B) in the left ventricle. 
Data are expressed as means  S.E.M. from n=6-7 samples. White bar indicates sham animals. Blue bar 
indicates normothermic animals (NT=38°C) that received LPS. Red bar indicates animals that received 
LPS and assigned to mild hypothermia (HT=33°C). p<0.05 vs. Sham.  
 
On the other hand, protein expression of PTHrP system was analyzed as well, as shown in 
Fig.20. Endotoxin administration at 38°C did not alter significantly the PTHrP protein expression 
but when temperature was decreased to 33°C, it reduced the protein expression (Fig. 20A and 
20C). LPS decreased the protein expression of PTH-1R (Fig. 20B and 20D) in a temperature 
dependent way. However, there were no significant changes observed regarding protein 
expression of PTHrP and its corresponding receptor. LPS and mild hypothermia seemed to 
affect differently the expression of PTHrP system in the cardiovascular system.  
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Figure 20. Effect of LPS on protein expression of PTHrP and PTH-1R in the left ventricle. 
Representative western blots (A) and (B), respectively; mean protein expression (C) and (D), respectively. 
Data are expressed as means  S.E.M. from n=6-7 samples. White bar indicates sham animals. Blue bar 
indicates normothermic animals (NT=38°C) that received LPS. Red bar indicates animals that received 
LPS and assigned to mild hypothermia (HT=33°C). p<0.05 vs. Sham.  
 
TGF-ß1 mRNA expression elevated under sepsis conditions compared to control group as seen 
in Fig. 21A. Hypothermia increased its expression towards normothermia, in contrast to liver 
(Fig. 18A) where temperature decrease, reduced the cytokine expression bringing to constitutive 
levels in the liver.  
As displayed in Fig. 21B, there was a difference in the collagen type I expression in liver and 
heart. Endotoxin administration at constant temperature did reduce its expression but on the 
other hand, hypothermia increased the mRNA of COL1A1. It suggests that increased expression 
of TGF-ß1 during mild hypothermia may influence the increase of ECM protein collagen type I in 
the heart. 
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Figure 21. Effect of endotoxin on mRNA expression of PTHrP potential downstream targets, TGF-
ß1 (A) and Collagen-1 (B) in left ventricle. Data are expressed as means  S.E.M. from n=6-7 samples. 
White bar indicates sham animals. Blue bar indicates normothermic animals (NT=38°C) that received 
LPS. Red bar indicates animals that received LPS and assigned to mild hypothermia (HT=33°C). p<0.05 
vs. Sham.   
 
Hypothermia influenced the left ventricle of the heart differently compared to lung and liver. 
PTHrP mRNA expression was stronger, protein expression of PTH-1R was reduced and 
COL1A1 mRNA was increased in the left ventricle of hypothermic pigs. Therefore, this suggests 
that hypothermia affects differentially the PTHrP system in the heart compared to other tissue 
organs investigated under endotoxemia.   
Furthermore, Langendorff perfused rat hearts were used to find out if this cardiovascular specific 
effect of temperature on the expression of PTHrP in LPS-treated pigs indicates a participation of 
PTHrP in the protective effect of moderate hypothermia and whether LPS modifies receptor 
responsiveness, the role of temperature alteration in this case.  
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3.3. Effects of hypothermia and LPS on PTHrP expression in vitro  
3.3.1. Effects of endotoxin and temperature on MCP-1 in Langendorff perfused 
hearts 
The observed results in pigs so far revealed not similar effects of LPS and hypothermia on 
organs under investigation. Endotoxin increased the mRNA expression of the pro-inflammatory 
cytokine MCP-1 in liver, left ventricle, aorta and lung. Mild hypothermia did not show significant 
variation in comparison with normothermia.   
The previous results in pigs concerning the effect of temperature on pro-inflammatory cytokine 
MCP-1 and cardiac expression of PTHrP in a model of endotoxemia caused by LPS could be 
reproduced in the Langendorff rat heart system. 
As described earlier, hearts in the Langendorff system were perfused with LPS for 2 hours and 
lastly PTHrP (1-34) 100 mM was added for 10 minutes. Experiments were carried out at different 
temperatures, namely 37°C and 32°C in order to find out this cardiovascular specific effect of 
temperature on the PTHrP expression in experimental endotoxemia and to investigate the 
functional response to PTHrP.  
Fig.22 shows the mRNA expression of the pro-inflammatory cytokine MCP-1 where it is obvious 
that LPS significantly induced cytokine mRNA levels regardless of temperature. The same 
results were obtained from experiments performed in different tissue organs like liver lung, aorta, 
and left ventricle of the pigs indicating a sepsis condition after the endotoxin administration. 
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Figure 22. mRNA expression of MCP-1 in the left ventricle of Langendorff perfused hearts after 
LPS treatment at different temperatures. Data are expressed as means  S.E.M. from n=6-7 samples. 
Red bars indicate rat hearts, either control or those that received LPS at 37°C. Blue bars indicate rat 
hearts, either control or those that received LPS at 32°C. *; p 0.05 
 
3.3.2. Effects of endotoxin and temperature on PTHrP expression in Langendorff 
perfused hearts 
As for PTHrP, LPS did elevate its expression in the lung and liver of septic pigs and temperature 
change did not have significant effect, whereas, cardiovascular system under endotoxin effect 
influenced the PTHrP system, downregulating its expression in a temperature dependent way. 
Hearts perfused in the Langendorff apparatus showed that LPS differentially changed the 
expression of PTHrP (Fig.23) in a temperature dependent way. PTHrP mRNA was higher in 
hearts subjected to hypothermia than to normothermia-treated ones under experimental 
endotoxemia. 
mRNA expression of PTH-1R displayed no significant changes (data not shown). 
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Figure 23. mRNA expression of PTHrP in the left ventricle of Langendorff perfused hearts after 
LPS treatment at different temperatures. Data are expressed as means  S.E.M. from n=6-7 samples. 
Red bars indicate rat hearts, either control or those that received LPS at 37°C. Blue bars indicate rat 
hearts, either control or those that received LPS at 32°C. *; p<0.05   
 
3.3.3. Effects of endotoxin and temperature on cardiovascular functional 
parameters 
Experiments on Langendorff rat heart system revealed similar findings as those on pigs 
regarding the effect of temperature on cardiac expression of PTHrP. Furthermore, functional 
parameters of heart like left ventricular developed pressure (LVDP) and heart rate could be 
recorded in the heart during the period of LPS perfusion and after adding the PTHrP (1-34) 100 
mM to understand potential changes in cardiac function as a result of temperature modification. 
A typical measure of cardiac function, the LVDP is shown in Fig.24. Endotoxin administration for 
2 hours did not change significantly the LVDP. Keeping the temperature at 37°C under LPS 
effect increased moderately the LVDP while decreasing the temperature to 32°C reduced the 
LVDP. However, in both cases the effect of LPS on LVDP was not significant during 2 hours, 
indicating that cardiac contractility was not affected significantly by endotoxin and temperature. 
The LPS concentration was lower than required to display direct cardio-depressive effects.  
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Figure 24. Left ventricular developed pressure (LVDP) 2 hours after LPS perfusion of rat hearts. 
Data are expressed as means  S.E.M. from n=6-7 samples. Red bars indicate rat hearts, either control or 
those that received LPS at 37°C. Blue bars indicate rat hearts, either control or those that received LPS at 
32°C. p<0.05 vs. Ctr. 
 
Similar effect of LPS was found on heart rate of the rats. Adding the LPS at 37°C reduced the 
HR compared to control (Fig. 25) while LPS addition at 32°C increased the HR. Still the 
endotoxin effect was not significant during 2 hours perfusion.  
Both cardiac parameters, LVDP and HR were not influenced significantly from the LPS 
administration and mild hypothermia.  
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Figure 25. Heart rate (HR) 2 hours after LPS perfusion of rat hearts. Data are expressed as means  
S.E.M. from n=6-7 samples. Red bars indicate rat hearts, either control or those that received LPS at 
37°C. Blue bars indicate rat hearts, either control or those that received LPS at 32°C. p<0.05 vs. Ctr. 
 
3.3.4. Effects of PTHrP and temperature on cardiovascular functional parameters 
The contraction force of the heart, namely the LVDP was analysed not only under LPS 
conditions but also after adding the PTHrP agonist (PTHrP (1-34)) at different temperatures. 
Hearts receiving endotoxin at 37°C for 2 hours displayed a drop in left ventricular developed 
pressure following 10 min PTHrP stimulation. However, the agonist did not have significant 
effect at 37°C (Fig.26).  In hearts treated at 32°C, the agonist increased LVDP, a positive 
contractile effect was seen, indicating that PTHrP responsiveness is improved in LPS treated 
hearts under hypothermic conditions. The data suggest a different receptor responsiveness of 
PTH receptor under hypothermia and normothermia.  
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Figure 26. Left ventricular developed pressure (LVDP) ten min after PTHrP (1-34) (100 mM) 
administration in LPS-treated rat hearts. Data are expressed as means  S.E.M. from n=6-7 samples. 
Red bars indicate rat hearts, either control or those that received LPS at 37°C. Blue bars indicate rat 
hearts, either control or those that received LPS at 32°C. *; p0.05 vs. pre-application of PTHrP 
 
Short-term PTHrP stimulation decreased the heart rate of LPS-treated rat heart under 
normothermia, as shown in Fig.27 with red bars. However, the decrease was more pronounced 
in hearts treated under hypothermic conditions, suggesting repression in PTHrP responsiveness 
in mild hypothermia (Fig.27 blue bars).  
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Figure 27. Heart rate (HR) ten min after PTHrP (1-34) (100 mM) administration in LPS-treated rat 
hearts. Data are expressed as means  S.E.M. from n=6-7 samples. Red bars indicate rat hearts, either 
control or those that received LPS at 37°C. Blue bars indicate rat hearts, either control or those that 
received LPS at 32°C. *; p<0.05 vs. pre-application of PTHrP  
 
3.3.5. Effect of PTHrP on MAPK activation 
The effect of temperature and PTHrP on activation of ERK2 (also known as p42 or MAPK1, a 
member of extracellular-signal-regulated kinase family) as a downstream target of PTH receptor 
stimulation, in LPS treated hearts was investigated by western blot analysis. As displayed in Fig. 
28A, LPS treatment at different temperatures or administration of short-term PTHrP did not 
affect the total p42 protein levels, used as control value. PTHrP administration increased the 
phosphorylated ERK2 expression in LPS treated hearts at 32°C compared to normothermic rat 
hearts (Fig. 28A and 28B). Results indicate an induction in PTHrP responsiveness (ERK 
activation) in hearts treated with LPS under hypothermic conditions.   
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Figure 28. Effect of PTHrP on protein expression of ERK2 in LPS treated hearts. Representative 
western blot of p42 (loading control) and p42 phospho (A); mean protein expression (B). Data are 
expressed as means  S.E.M. from n=6 samples. Red bar indicates rat hearts that received LPS at 37°C. 
Blue bar indicates rat hearts that received LPS at 32°C. *, p0.05 vs. 37oC 
 
3.3.6. Effect of LPS and PTHrP receptor antagonism on cell shortening 
Mechanical properties of isolated adult rat ventricular myocytes were monitored by cell-edge 
detection method. Using this system, the cell shortening was determined in cardiomyocytes 
treated with endotoxin in normothermic and hypothermic conditions and after administration of 
PTH/PTHrP receptor antagonist, PTHrP (7-34) 100 nM. Keeping the stimulation frequency 2Hz 
the contractility of the cell was measured and presented as a percentage of the cell length while 
resting. So far, results revealed an induction in PTHrP responsiveness in LPS treated hearts, 
therefore blocking the receptor under normo- and- hypothermia was the next aim of 
investigation. 
42 kDa 
42 kDa 
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As shown in Fig. 29, the shortening of the LPS treated cells was decreased after antagonist 
administration under normothermic conditions. Cardiac myocytes treated with endotoxin under 
hypothermia showed slight increase in cell shortening compared to normothermia. When the 
receptor antagonist was added to cardiomyocytes treated under hypothermic conditions, it 
increased the cell shortening. Thus, in both cases a slight change in cell shortening was 
monitored, however it was not significant. Therefore, it could be concluded that LPS treatment 
and receptor-antagonist responsiveness is different in LPS treated isolated rat ventricular 
myocytes under temperature alteration. However, blocking the receptor under hypothermic 
conditions increased more the contraction amplitude than normothermia. This temperature-
dependent increase in contraction amplitude of the cells indicates that PTHrP (7-34) 
responsiveness is higher under hypothermic conditions.  
 
 
 
Figure 29. Effect of PTHrP (7-34) on cell shortening in LPS-treated isolated cardiomyocytes at 
different temperatures. Data are expressed as means  S.E.M. from n=27 cells. Red bars indicate 
cardiac myocytes, either control that received only LPS or those that received LPS and PTHrP (7-34) at 
37°C. Blue bars indicate cardiac myocytes, either control that received only LPS or those that received 
LPS and PTHrP (7-34) at 32°C. *, p<0.05 vs. 37oC 
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4. Discussion 
4.1. Effects of high fat diet, ageing and ischemia/reperfusion on pulmonary 
PTHrP system in mice 
The study reveals the role of different stressors in PTHrP expression in the lung. As regards high 
fat diet, it increased the steady state pulmonary mRNA expression of PTHrP in vivo under basal 
conditions. ADRP and PPARγ, the downstream targets of PTHrP were upregulated by high fat 
diet, as well. Elevated PTHrP expression may be associated with increased leptin levels, as 
Torday and Rehan (2007) elucidated the interaction between leptin and PTHrP expression. 
Experiments performed in leptin deficient mice (data not shown) showed downregulation of 
PTHrP mRNA expression in the lung. However, the reduced mRNA expression of pulmonary 
PTHrP in B6.V-Lepob/J mice did not lead to alterations in the mRNA expression of PTHrP 
dependent genes.  
High fat diet, cardiac ischemia/reperfusion, and ageing elevated the mRNA levels of PTHrP and 
the downstream targets in adult mice; however, they had no significant effect in the pulmonary 
mRNA expression of PTHrP in older mice.  
PTHrP is considered pivotal in epithelial-mesenchymal paracrine cross talk, being involved in 
surfactant production. Torday and Rehan (2007) elaborated this process in detail, demonstrating 
the communication between epithelial cells with alveolar type II cells via release of leptin (Torday 
and Rehan 2002). Exactly this positive feedback of the communication between two cell types 
has prompted us to investigate the role of high fat diet in the pulmonary expression of PTHrP, 
whether increase in leptin levels due to high fat diet could modify the PTHrP expression. This 
fact was proved by experiments. High fat diet elevated the leptin levels and this led to increase 
in mRNA expression of PTHrP in the lung. The expression of the corresponding receptor, PTH-
1R, was not affected by high fat diet. PTHrP protein level was not induced under these 
conditions, indicating that there is a higher turnover of PTHrP. Therefore, our data suggest that 
high turnover of PTHrP is indicative for an activation of the PTHrP system in the lung, owing to 
the fact that PTHrP downstream target genes like ADRP and PPARγ appeared to be 
upregulated as well.  
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Induction of the PTHrP-driven epithelial-mesenchymal cross talk was assessed by numerous 
studies as a protective mechanism which provides better oxygenation of the pulmonary blood 
(Torday and Rehan (2007); Stern, Bernard et al. (2002)). PTHrP is known to contribute in 
developing and stabilizing the lung function through several mechanisms including the regulation 
of branching morphogenesis and type II cell maturation, the process of surfactant production 
which improves oxygen uptake, vasodilatation that improves perfusion, inhibition of lipofibroblast 
transdifferentiation into myofibroblasts (Torday and Rehan (2007); Hastings (2004)). Results 
obtained from our investigation regarding elastin revealed no alteration in its mRNA expression 
under any of the conditions, which complies with findings that increase in elastin expression may 
be a characteristic of interstitial pulmonary fibrosis that leads to altered lung mechanics (Cantor, 
Keller et al. (1987); Lucey, Ngo et al. (1996); Kuang, Zhang et al. (2007)). 
Several conditions are known to alter the pulmonary development and function by inhibiting the 
protective role of PTHrP like barotrauma, oxytrauma, prematurity, infection and nicotine (Rehan, 
Wang et al. (2005); Rehan, Sakurai et al. (2007); Doi, Lukosiute et al. (2010); Hastings, Ryan et 
al. (2002)). Our findings could prove that myocardial infarction and ageing do not belong to these 
kinds of inhibitory factors.  
On the other hand, the obesity paradox is a condition, which describes the fact that obese 
people tolerate ischemic events better than people of normal weight do. We hypothesized that 
such a situation is accompanied by better PTHrP-driven epithelial-mesenchymal paracrine cross 
talk. Experiments performed on mice fed with high fat diet but not subjected to myocardial 
infarction showed an increase in pulmonary expression of PTHrP.  
Mice fed with high fat diet compared to those fed with normal diet, when both underwent 
ischemia/reperfusion, displayed a significant improvement in PTHrP and PTH-1R protein 
expression. This upregulation may indicate a more appropriate coupling of PTHrP and PTH-1R 
system in the high fat diet group, suggesting that PTHrP under these conditions could stimulate 
its corresponding receptor turning on a self-stimulation mechanism. High fat diet may be 
beneficial for lung function; however, this cannot be concluded from this study.  
According to Vinten-Johansen and Shi (2011) ageing leads to reduction or even loss of 
protective mechanisms. In this study, the effect of high fat diet on ageing was analyzed. Seven-
month-old mice were compared to thirteen-month old ones. In older mice, PTHrP mRNA 
expression was increased in contrast to elastin levels, which were low. The mRNA of PTHrP in 
older mice was higher than in young ones in the case when mice were fed with standard diet 
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and experienced only sham surgery. However, high fat diet had no significant influence on older 
mice. 
The result obtained from experiments was expected knowing the assumption as how PTHrP 
attenuates epithelial-mesenchymal transition to fibrosis. High PTHrP levels lead to elevation of 
downstream molecules like ADRP and PPARγ and reduce the endothelial transdifferentiation 
into fibroblasts. Our experiments showed that high fat diet has no significant effects on 
pulmonary expression of PTHrP and PTHrP-dependent regulated targets in older mice. Its effect 
was more pronounced in younger mice than in older ones. PPARγ expression in lungs of 
thirteen-month-old mice was significantly elevated though. In general, PPARγ mRNA expression 
in the lung was more closely linked to high fat diet than that of PTHrP, PTH-1R or ADRP. The 
overall data show that high fat diet can modify the pulmonary mRNA expression of PTHrP in 
young mice.  
Finally, this study reveals a pivotal effect of leptin on the steady state level of PTHrP mRNA in 
vivo. Ischemia/reperfusion and ageing elevated the PTHrP mRNA expression but not the entire 
PTHrP system was induced. The high fat diet effect on mRNA expression of PTHrP in lungs of 
young mice may contribute the observations that are generally named the obesity paradox.  
 
4.2. Effects of hypothermia on PTHrP system in endotoxemic pigs and rats  
As shown by other studies, it could be confirmed by our experiments as well that endotoxemia 
induces the PTHrP system in multiple tissues. The target of this investigation was to find out the 
role of hypothermia in increased expression of PTHrP in endotoxemic animals. Therefore, the 
study reveals that PTHrP-responsiveness in the heart is altered under hypothermic conditions, 
which ameliorates the cardiac function. This led us to conclude that hypothermia has beneficial 
effects on sepsis.  
Earlier findings by Funk, Krul et al. (1993) regarding endotoxin, namely LPS have demonstrated 
increase in the PTHrP mRNA expression in the spleen of mice. Later on studies found elevation 
of PTHrP mRNA expression in different organs after administration of a near lethal dose of LPS, 
while inhibition of PTHrP led to delay in mice mortality (Funk, Moser et al. (1996); Funk, Moser 
et al. (1997)). In accordance with these studies, we could confirm the effects of LPS on PTHrP 
system in various tissue organs of a large animal model with a different experimental 
endotoxemia model. Sublethal dose of LPS was given to the animal for four hours and an 
increase in PTHrP mRNA in lung and liver was seen 8 hours after the LPS administration.  
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Concerning PTH-1R, it was found that LPS downregulates the receptor mRNA expression in 
rodents (Funk, Moser et al. 1997). Using PTHrP antagonist downregulated the mRNA 
expression but it was still a functional receptor (Funk, Krul et al. 1993). Our experiments showed 
that hypothermia downregulated and desensitized the PTH-1R mRNA expression in liver, heart, 
and lung. However, the protein expression was not significantly downregulated in liver and lung. 
The data suggest a causal role for PTH-1R downregulation in the beneficial effects of 
hypothermia. The disruption of PTH-1R system may be enhanced under mild hypothermia and 
contribute to better outcome. 
Torday and Rehan (2007) proved that PTHrP in the lung is an essential factor for maintaining 
the epithelial-mesenchymal cross talk by regulating the expression of some downstream 
molecules. Therefore, we analyzed ADRP, as one of these PTHrP-dependent molecules, and 
observed an increase in pulmonary ADRP expression under normothermia in septic pigs. 
Pulmonary PTHrP mRNA and protein expression was increased. The obtained results indicate 
that LPS activates the PTHrP system in the lung. In the liver PTHrP protein expression was 
reduced which lets us to understand that there is a high turnover of PTHrP. However, this does 
not mean that PTHrP system is not important for liver function. Li, Seitz et al. (1996) elucidated 
the role of PTHrP in the liver as an autocrine or paracrine growth factor contributing in the 
regulation of hepatocyte proliferation.  
When it comes to hypothermia, it was used as a method to make a better prognosis in the case 
of experimental endotoxemia. Data indicate that hypothermia decreases the mRNA expression 
of ADRP, therefore leading to a disruption of PTHrP-ADRP axis in the lung and this may 
contribute to the better functional recovery of the pigs. As described by Schwarzl, Seiler et al. 
(2013), hypothermia improves the heart contraction and respiratory function. In our model of 
experimental endotoxemia, hypothermia had an impact on the response of the PTHrP system 
particularly in the heart. In other words, hypothermia elevated the mRNA expression of PTHrP in 
the pig and rat model. When the effect of normothermia was compared to hypothermia in 
endotoxemic hearts, the different receptor responsiveness was remarkable. It was demonstrated 
that cardiac stress could acutely modify the PTH-1R responsiveness (Jansen, Gres et al. 2003) 
as the dose of PTHrP (1-34) needed to cause maximum vasodilatation in stunned myocardium 
was reduced remarkably, indicating a change in the density or to the endothelium-mediated 
effects of the receptor. 
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According to our data in isolated perfused rat hearts, PTHrP increased LVDP in hearts subjected 
to endotoxin under hypothermic but not normothermic conditions. Subsequently a significant 
activation of the protein kinase ERK was observed. ERK activation and functional improvement 
in rat hearts under hypothermia might be coupled; however, this has not been mechanistically 
investigated in the study because the aim was to find out the potential hypothermia-dependent 
changes in PTHrP responsiveness.  
Measuring the cell shortening of isolated cardiomyocytes, we could show that PTHrP can 
improve the cardiac contractility in endotoxemia under hypothermic but not normothermic 
conditions. We could say that hypothermia effectively couples PTHrP receptors to positive 
contractility and that under hypothermic conditions the ventricular PTHrP system is activated. 
Data suggest that activation of the PTHrP signalling cascade contributes to the cardiovascular 
stabilizing effect of hypothermia in endotoxemia. Hypothermia improves cardiac effectiveness by 
increasing inotropy but decreasing chronotropy allowing the heart to maintain cardiac output at 
lower energy costs. This effect is caused by Gαq-coupled PTHrP receptors (in vitro in isolated 
rat hearts and isolated cardiomyocytes) as shown in Fig. 30. The aforementioned effects may 
contribute to the beneficial acute effect of moderate hypothermia in critically ill septic patients.  
Data add evidence to an essential role of PTHrP system in proinflammatory signal transduction 
during endotoxemia and further demonstrate that mild hypothermia beneficially influences this 
pathway, suggesting that PTHrP may be involved in the protective effects of hypothermia under 
septic conditions. Temperature influences the effect of LPS on cardiac expression of PTHrP and 
receptor responsiveness independent of its effect on pro-inflammatory cytokines (in vivo in pigs; 
in vitro in isolated rat hearts). As described by Schwarzl, Seiler et al. (2013), in the same pig 
model LPS administration led to increased expression of classical proinflammatory cytokines 
(tumor necrosis factor-α, and interleukin 6 and 8) independently of temperature. In accordance 
with these data, our experiments showed steadily elevation in NFκB-target MCP-1 expression in 
all tissues under investigation, independently of temperature. This emphasizes the role and 
significance of PTHrP in temperature dependent alterations and especially under hypothermic 
conditions in experimental endotoxemia.   
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Figure 30. Proposed mechanism in this study: Hypothermia shifts PTHrP receptor responsiveness 
from Gαs to Gαq coupling. Hypothermia improves cardiac function in models of endotoxemic stress 
mimicking a sepsis related condition by modifying the expression and function of cardiac PTHrP receptors.  
Clinical perspective of this study seems to be substantial. HFD by increasing the interaction 
between Leptin-PTHrP in the lung may contribute to lung remodeling and favor the adult obese 
patients who experience infarction, attenuating the complications following myocardial infarction, 
thereby improving the post-infarct outcome. However, HFD may not favor the obese old patients. 
On the other side, mild hypothermia may attenuate and stabilize the cardiac dysfunction during 
experimental sepsis, suggesting improvement in the outcome of patients with sepsis.  
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5. Summary 
Myocardial infarction and sepsis are considered as devastating diseases in the world. 
Myocardial ischemia occurs when blockage of one or more coronary arteries reduces the blood 
flow to the heart. Thus, the amount of oxygen that myocardium receives decreases. Sepsis is a 
systemic immune response to the infection caused mostly by bacteria. 
Therefore, the current study aimed to discover the role of high fat diet and ageing in PTHrP 
system under ischemia/reperfusion in order to explain the so-called obesity paradox, and the 
role of hypothermia in vital organs, in particular the cardiac expression of PTHrP under 
endotoxemia.  
Results suggest an age-dependent expression of PTHrP, being highly elevated in older mice 
rather than in adult mice. High fat diet affected the expression of PTHrP, its corresponding 
receptor and the downstream molecules ADRP and PPARγ. Ischemia/reperfusion increased the 
mRNA expression of PTHrP and ADRP in the lung but it had no significant effect on PTH-1R 
and PPARγ. Results corroborate the activation of the pulmonary paracrine pathway under stress 
conditions, especially under HFD.  
Concerning LPS, it induces the PTHrP system in the lung and liver but temperature alteration did 
not have any significant impact. Left ventricle revealed opposite results compared to other vital 
organs as LPS downregulated the mRNA of PTHrP and PTH-1R. To verify the downregulation of 
the PTHrP system in the heart, in vitro experiments performed in the Langendorff apparatus, and 
in vivo experiments in pigs showed that hypothermia improved mRNA expression of PTHrP in 
the heart. Hypothermia improved the PTHrP responsiveness in septic hearts as one of the 
functional parameters of the heart, the LVDP that represents the cardiac contractility, cell 
shortening of isolated rat heart cells and phosphorylation of ERK (ERK2) were increased under 
septic conditions.  
 
Therefore, we hypothesize that high fat diet may increase the expression of PTHrP system in the 
lung under ischemia/reperfusion and thereby may improve the epithelial-mesenchymal paracrine 
cross talk in the lung, the paracrine loop important for pulmonary function. Increase of leptin and 
other PTHrP downstream targets may stabilize the pulmonary remodeling after 
ischemia/reperfusion, which describes the obesity paradox. The current data indicate that 
hypothermia influences the cardiac expression of PTHrP under septic conditions, which 
suggests that PTHrP participates in improving the cardiac function in this situation. 
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6. Zusammenfassung 
Der Myokardinfarkt und septische Ereignisse gehören zu den schwerwiegensten Erkrankungen 
weltweit. Ein Moykardinfark entsteht, wenn eine oder mehrere Koronargefäße eingeengt oder 
verschlossen sind. In der Folge wird das Myokard sauerstoffarm. Eine Sepsis ist eine 
systemische Immunantwort auf eine generalisierte bakterielle Infektion. 
Aus diesem Grunde wurde in die vorliegenden Studie näher untersucht, welchen Einfluss ein 
Myokardinfarkt und eine sterile Infektion mit LPS auf die gewebespezifische Expression von 
PTHrP hat, und ob dies durch fettreiche Diät zur Erzeugung eines „obesity paradox“ oder durch 
Hypothermie zum besseren Schutz der betroffenen Organe beeinflusst wird. 
 
Die Ergebnisse suggerieren eine altersabhängige Expression von PTHrP, die im Alter zunimmt. 
Eine fetthaltige Diät beeinflusst die Expression von PTHrP, seines Rezeptors und seiner 
Targetgene ADRP und PPARγ. In der Folge einer Reperfusion nach myokardialer Ischämie 
steigt die pulmonale Expression von PTHrP und ADRP aber nicht die des Rezeptors und des 
PPARγ. Die Ergebnisse suggerieren eine Aktivierung des pulmonalen PTHrP Systems bei 
fettreicher Ernährung. 
 
In Bezug auf LPS konnte gezeigt werden, dass LPS die pulmonale und hepatische Expression 
steigert ohne dass eine Hypothermie darauf Einfluss nimmt. Im Gegensatz dazu wurde im linken 
Ventrikel des Herzens PTHrP herabreguliert. Diese Befunde konnte in vitro und in vivo verifiziert 
werden und im Herzen kam es unter Hypothermie zu einer Normalisierung der Expression von 
PTHrP und einer funktionellen Verbesserung. In ähnlicher Weise reagierten isolierte 
Herzmuskelzellen auf LPS und Hypothermie (Verbesserte lastfreie Zellverkürzung, ERK2-
Aktivierung). 
 
Aus diesen Befunden lässt sich suggerieren, dass eine fettreiche Ernährung zu einer 
verbesserten Stimulation des PTHrP-Systems in der Lunge nach Infarktereignissen beiträgt und 
dass dies zumindest partiell zum „obesity paradox“ beitragen könnte. Ausserdem zeigen die 
Befunde, dass Hypothermie die kardiale Expression von PTHrP normalisiert und dadurch zu 
einer verbesserten kardialen Funktion hypotherm exponierten Sepsis-Patienten beiträgt.    
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7. List of Abbreviations  
AC Adenylyl Cyclase 
ADRP Adipocyte differentiation-related protein 
B2M β2-microglobulin 
Bcl-2 B-cell lymphoma 2 protein 
BPB Bromophenol blue   
BSA Bovine serum albumin 
cAMP 3’,5’- cyclic adenosine monophosphate   
CaSR Calcium-sensing receptor 
cDNA Complementary DNA 
COL1A1 Collagen, type I, alpha 1 
CVR Coronary vascular resistance   
DAG Diacylglycerol 
dNTP’s Nucleotide triphosphates containing deoxyribose 
DTT Dithiothreitol 
ECL Enhanced Chemiluminescence Detection 
ERK-2 Extracellular signal-regulated kinase 2 
FCS Fetal calf serum 
GAPDH Glyceraldehyde-3-Phosphate Dehydrogenase 
Gli-3 Zinc finger protein 
HFD High fat diet 
HHM    Humoral hypercalcemia of malignancy 
HPRT Hypoxanthine phosphoribosyltransferase 
HT   Hypothermia 
I/R Ischemia/Reperfusion 
IHH Indian Hedgehog protein 
IL-1 Interleukin 1 
IP3 1,4,5 inositol triphosphate 
KCl Potassium chloride 
KHB Krebs-Henseleit Buffer 
LPS Lipopolysaccharide 
LVDP Left ventricular developed pressure 
LVEDP Left ventricular end diastolic pressure 
LVSP Left ventricular systolic pressure 
MAPK Mitogen-activated protein kinase 
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MCP-1 Monocyte chemoattractant protein-1 
M-MLV-RT Reverse transcriptase from Moloney murine leukemia virus 
MOPS buffer 3-(N-morpholino) propanesulfonic acid          
mRNA messenger RNA 
NaCl Sodium chloride 
ND Normal Diet 
NO Nitric oxide 
NT Normothermia 
Oligo dt A short sequence of deoxy-thymine nucleotides 
p57 Cyclin-dependent kinase inhibitor 1C 
PKA   Protein kinase A   
PKC Protein kinase C 
PLC Phospholipase C 
PMSF Phenylmethylsulfonyl fluoride 
PPARγ Peroxisome proliferator-activated receptor gamma 
PTH   Parathyroid hormone   
PTH-1R Parathyroid hormone receptor type I 
PTH-2R Parathyroid hormone receptor type II 
PTHrP   Parathyroid hormone related protein 
qRT-PCR     Quantitative real-time-polymerase chase reaction 
RNAsin Ribonuclease inhibitor 
ROS Reactive oxygen species 
Runx2 Runt-related transcription factor 2 
SDS-PAGE Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SOX9   SRY (sex determining region Y)-box 9 
TBS buffer Tris-buffered saline buffer 
TBST buffer Tris-buffered saline and Tween 20 
TGF-β1 Transforming growth factor beta 1 
TIP39 Tuberoinfundibular peptide of 39 residues   
TNF-α Tumor necrosis factor alpha 
Tris-HCl Tris (hydroxymethyl) aminomethane hydrochloride 
                        
 
 
 
79 
 
8. List of Figures and Tables 
Figure 1. Intracellular signalling pathway of PTH/PTHrP receptor on chondrocytes. .................... 7 
Figure 2. Model of lung evolution, development, homeostasis, and repair. ................................ 10 
Figure 3. Inflammatory pathway initiated by TNF and IL-1 ......................................................... 13 
Figure 4. Pathway of cytokines and PTHrP in injury .................................................................. 14 
Figure 5. Langendorff heart perfusion model. ............................................................................ 29 
Figure 6. Perfusion flow of rat hearts in the Langendorff system ............................................... 31 
Figure 7. Pulmonary mRNA expression of PTHrP, PTH-1R, ADRP, and PPARγ in seven months 
old mice ..................................................................................................................................... 42 
Figure 8. Pulmonary mRNA expression of PTHrP, PTH-1R, ADRP, and PPARγ in thirteen-
month-old mice .......................................................................................................................... 44 
Figure 9. Pulmonary protein expression of PTHrP and the corresponding PTH-1R in seven 
months old mice ........................................................................................................................ 46 
Figure 10. Pulmonary protein expression of PTHrP and the PTH-1R in thirteen months old mice
 .................................................................................................................................................. 47 
Figure 11. Pulmonary mRNA expression of elastin in seven or thirteen months old mice. ......... 48 
Figure 12. mRNA expression of MCP-1 in different tissues after LPS-treatment........................ 50 
Figure 13. Pulmonary mRNA expression of PTHrP (A) and PTH-1R (B) in the lungs of septic 
pigs ........................................................................................................................................... 51 
Figure 14. Effect of LPS on protein expression of PTHrP and PTH-1R in the lung. ................... 52 
Figure 15. Effect of LPS on pulmonary mRNA expression of PTHrP downstream targets, ADRP 
and Bcl-2  .................................................................................................................................. 53 
Figure 16. mRNA expression of PTHrP and PTH-1R in the liver of septic pigs. ......................... 54 
Figure 17. Effect of LPS on protein expression of PTHrP and PTH-1R in the liver ..................... 55 
Figure 18. Effect of LPS on mRNA expression of PTHrP downstream targets, TGF-ß1 and 
Collagen-1 in the liver ................................................................................................................ 56 
Figure 19. Effect of LPS on mRNA expression of PTHrP and PTH-1R in the left ventricle. ........ 57 
Figure 20. Effect of LPS on protein expression of PTHrP and PTH-1R in the left ventricle.. ...... 58 
Figure 21. Effect of endotoxin on mRNA expression of PTHrP potential downstream targets, 
TGF-ß1 and Collagen-1 in left ventricle. .................................................................................... 59 
Figure 22. mRNA expression of MCP-1 in the left ventricle of Langendorff perfused hearts after 
LPS treatment at different temperatures .................................................................................... 61 
Figure 23. mRNA expression of PTHrP in the left ventricle of Langendorff perfused hearts after 
LPS treatment at different temperatures .................................................................................... 62 
80 
 
Figure 24. Left ventricular developed pressure (LVDP) 2 hours after LPS perfusion of rat hearts.
 .................................................................................................................................................. 63 
Figure 25. Heart rate (HR) 2 hours after LPS perfusion of rat hearts ......................................... 64 
Figure 26. Left ventricular developed pressure (LVDP) ten min after PTHrP (1-34) (100 mM) 
administration in LPS-treated rat hearts .................................................................................... 65 
Figure 27. Heart rate (HR) ten min after PTHrP (1-34) (100 mM) administration in LPS-treated 
rat hearts ................................................................................................................................... 66 
Figure 28. Effect of PTHrP on protein expression of ERK2 in LPS treated hearts ...................... 67 
Figure 29. Effect of PTHrP (7-34) on cell shortening in LPS-treated isolated cardiomyocytes at 
different temperatures ............................................................................................................... 68 
Figure 30. Proposed mechanism in this study: Hypothermia shifts PTHrP receptor 
responsiveness from Gαs to Gαq coupling ................................................................................ 74 
 
Table 1. Chemicals systematically used during the study .......................................................... 19 
Table 2. Primary antibodies ....................................................................................................... 21 
Table 3. Secondary antibodies .................................................................................................. 21 
Table 4. Mouse primers ............................................................................................................. 21 
Table 5. Pig primers .................................................................................................................. 22 
Table 6. Rat primers .................................................................................................................. 22 
Table 7. Materials used consistently in experiments .................................................................. 23 
Table 8. Instruments utilized during the study ............................................................................ 24 
Table 9. Software programs used in the study ........................................................................... 24 
Table 10. The diet induced obesity (DIO) formula ...................................................................... 26 
Table 11. Krebs-Henseleit Buffer (pH 7.4) ................................................................................. 30 
Table 12. Perfusion Buffer (Powell Medium) (pH 7.4, gassed with 95% O2/ 5% CO2) .............. 32 
Table 13. Cell culture media ...................................................................................................... 33 
Table 14. 10X Lysis Buffer ........................................................................................................ 37 
Table 15. Sample Buffer, Laemmli 2x Concentrate (pH 6.8) ...................................................... 38 
Table 16. Transfer Buffer ........................................................................................................... 39 
Table 17. 10xTBS Buffer (pH 7.4) ............................................................................................. 39 
 
 
81 
 
9. List of References 
Abou-Samra, A. B., H. Juppner, T. Force, M. W. Freeman, X. F. Kong, E. Schipani, P. Urena, J. 
Richards, J. V. Bonventre, J. T. Potts, Jr. and et al. (1992). "Expression cloning of a common 
receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-
like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol 
trisphosphates and increases intracellular free calcium." Proc Natl Acad Sci U S A 89(7): 2732-
2736. 
 
Cantor, J. O., S. Keller, I. Mandl and G. M. Turino (1987). "Increased synthesis of elastin in 
amiodarone-induced pulmonary fibrosis." J Lab Clin Med 109(4): 480-485. 
 
Carswell, E. A., L. J. Old, R. L. Kassel, S. Green, N. Fiore and B. Williamson (1975). "An 
endotoxin-induced serum factor that causes necrosis of tumors." Proc Natl Acad Sci U S A 
72(9): 3666-3670. 
 
Cerny, L., J. S. Torday and V. K. Rehan (2008). "Prevention and treatment of bronchopulmonary 
dysplasia: contemporary status and future outlook." Lung 186(2): 75-89. 
 
Childers, D. K. and D. B. Allison (2010). "The 'obesity paradox': a parsimonious explanation for 
relations among obesity, mortality rate and aging?" Int J Obes (Lond) 34(8): 1231-1238. 
 
Chorro, F. J., L. Such-Belenguer and V. Lopez-Merino (2009). "[Animal models of cardiovascular 
disease]." Rev Esp Cardiol 62(1): 69-84. 
 
Clemens, T. L., S. Cormier, A. Eichinger, K. Endlich, N. Fiaschi-Taesch, E. Fischer, P. A. 
Friedman, A. C. Karaplis, T. Massfelder, J. Rossert, K. D. Schluter, C. Silve, A. F. Stewart, K. 
Takane and J. J. Helwig (2001). "Parathyroid hormone-related protein and its receptors: nuclear 
functions and roles in the renal and cardiovascular systems, the placental trophoblasts and the 
pancreatic islets." Br J Pharmacol 134(6): 1113-1136. 
 
Comings, D. E. (1972). "Evidence for ancient tetraploidy and conservation of linkage groups in 
mammalian chromosomes." Nature 238(5365): 455-457. 
 
Copeland, S., H. S. Warren, S. F. Lowry, S. E. Calvano, D. Remick, Inflammation and I. the Host 
Response to Injury (2005). "Acute inflammatory response to endotoxin in mice and humans." 
Clin Diagn Lab Immunol 12(1): 60-67. 
 
Dinarello, C. A. (2000). "Proinflammatory cytokines." Chest 118(2): 503-508. 
 
Dobolyi, A., E. Dimitrov, M. Palkovits and T. B. Usdin (2012). "The neuroendocrine functions of 
the parathyroid hormone 2 receptor." Front Endocrinol (Lausanne) 3: 121. 
 
Doi, T., A. Lukosiute, E. Ruttenstock, J. Dingemann and P. Puri (2010). "Disturbance of 
parathyroid hormone-related protein signalling in the nitrofen-induced hypoplastic lung." Pediatr 
Surg Int 26(1): 45-50. 
82 
 
Donner, D., J. P. Headrick, J. N. Peart and E. F. du Toit (2013). "Obesity improves myocardial 
ischaemic tolerance and RISK signalling in insulin-insensitive rats." Dis Model Mech 6(2): 457-
466. 
 
Endlich, K., T. Massfelder, J. J. Helwig and M. Steinhausen (1995). "Vascular effects of 
parathyroid hormone and parathyroid hormone-related protein in the split hydronephrotic rat 
kidney." J Physiol 483 ( Pt 2): 481-490. 
 
Ferrari, S. L., R. Rizzoli and J. P. Bonjour (1994). "Effects of epidermal growth factor on 
parathyroid hormone-related protein production by mammary epithelial cells." J Bone Miner Res 
9(5): 639-644. 
 
Fortino, V., C. Torricelli, C. Gardi, G. Valacchi, S. Rossi Paccani and E. Maioli (2002). "ERKs are 
the point of divergence of PKA and PKC activation by PTHrP in human skin fibroblasts." Cell Mol 
Life Sci 59(12): 2165-2171. 
 
Frangogiannis, N. G. (2008). "The immune system and cardiac repair." Pharmacol Res 58(2): 
88-111. 
 
Funk, J. L., E. J. Krul, A. H. Moser, J. K. Shigenaga, G. J. Strewler, C. Grunfeld and K. R. 
Feingold (1993). "Endotoxin increases parathyroid hormone-related protein mRNA levels in 
mouse spleen. Mediation by tumor necrosis factor." J Clin Invest 92(5): 2546-2552. 
 
Funk, J. L., A. H. Moser, C. Grunfeld and K. R. Feingold (1997). "Parathyroid hormone-related 
protein is induced in the adult liver during endotoxemia and stimulates the hepatic acute phase 
response." Endocrinology 138(7): 2665-2673. 
 
Funk, J. L., A. H. Moser, G. J. Strewler, K. R. Feingold and C. Grunfeld (1996). "Parathyroid 
hormone-related protein is induced during lethal endotoxemia and contributes to endotoxin-
induced mortality in rodents." Mol Med 2(2): 204-210. 
 
Gruberg, L., N. J. Weissman, R. Waksman, S. Fuchs, R. Deible, E. E. Pinnow, L. M. Ahmed, K. 
M. Kent, A. D. Pichard, W. O. Suddath, L. F. Satler and J. Lindsay, Jr. (2002). "The impact of 
obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the 
obesity paradox?" J Am Coll Cardiol 39(4): 578-584. 
 
Hastings, R. H. (2004). "Parathyroid hormone-related protein and lung biology." Respir Physiol 
Neurobiol 142(2-3): 95-113. 
 
Hastings, R. H., R. M. Ryan, C. T. D'Angio, B. A. Holm, A. Patel, R. Quintana, E. Biederman, D. 
W. Burton and L. J. Deftos (2002). "Parathyroid hormone-related protein response to hyperoxic 
lung injury." Am J Physiol Lung Cell Mol Physiol 282(6): L1198-1208. 
 
Hilton, M. J., X. Tu, J. Cook, H. Hu and F. Long (2005). "Ihh controls cartilage development by 
antagonizing Gli3, but requires additional effectors to regulate osteoblast and vascular 
development." Development 132(19): 4339-4351. 
83 
 
Hiremath, M. and J. Wysolmerski (2013). "Parathyroid hormone-related protein specifies the 
mammary mesenchyme and regulates embryonic mammary development." J Mammary Gland 
Biol Neoplasia 18(2): 171-177. 
 
Jansen, J., P. Gres, C. Umschlag, F. R. Heinzel, H. Degenhardt, K. D. Schluter, G. Heusch and 
R. Schulz (2003). "Parathyroid hormone-related peptide improves contractile function of stunned 
myocardium in rats and pigs." Am J Physiol Heart Circ Physiol 284(1): H49-55. 
 
Jasmin, J. F., A. Calderone, T. K. Leung, L. Villeneuve and J. Dupuis (2003). "Lung structural 
remodeling and pulmonary hypertension after myocardial infarction: complete reversal with 
irbesartan." Cardiovasc Res 58(3): 621-631. 
 
Jasmin, J. F., I. Mercier, R. Hnasko, M. W. Cheung, H. B. Tanowitz, J. Dupuis and M. P. Lisanti 
(2004). "Lung remodeling and pulmonary hypertension after myocardial infarction: pathogenic 
role of reduced caveolin expression." Cardiovasc Res 63(4): 747-755. 
 
Jobe, A. H. and M. Ikegami (2001). "Biology of surfactant." Clin Perinatol 28(3): 655-669, vii-viii. 
 
Juppner, H., A. B. Abou-Samra, M. Freeman, X. F. Kong, E. Schipani, J. Richards, L. F. 
Kolakowski, Jr., J. Hock, J. T. Potts, Jr., H. M. Kronenberg and et al. (1991). "A G protein-linked 
receptor for parathyroid hormone and parathyroid hormone-related peptide." Science 254(5034): 
1024-1026. 
 
Kalogeris, T., C. P. Baines, M. Krenz and R. J. Korthuis (2012). "Cell biology of 
ischemia/reperfusion injury." Int Rev Cell Mol Biol 298: 229-317. 
 
Kirwin, S. M., V. Bhandari, D. Dimatteo, C. Barone, L. Johnson, S. Paul, A. R. Spitzer, A. 
Chander, S. G. Hassink and V. L. Funanage (2006). "Leptin enhances lung maturity in the fetal 
rat." Pediatr Res 60(2): 200-204. 
 
Kovacs, C. S. (2001). "Calcium and bone metabolism in pregnancy and lactation." J Clin 
Endocrinol Metab 86(6): 2344-2348. 
 
Kovacs, C. S., C. L. Ho-Pao, J. L. Hunzelman, B. Lanske, J. Fox, J. G. Seidman, C. E. Seidman 
and H. M. Kronenberg (1998). "Regulation of murine fetal-placental calcium metabolism by the 
calcium-sensing receptor." J Clin Invest 101(12): 2812-2820. 
 
Kovacs, C. S., B. Lanske, J. L. Hunzelman, J. Guo, A. C. Karaplis and H. M. Kronenberg (1996). 
"Parathyroid hormone-related peptide (PTHrP) regulates fetal-placental calcium transport 
through a receptor distinct from the PTH/PTHrP receptor." Proc Natl Acad Sci U S A 93(26): 
15233-15238. 
 
Koziel, L., M. Wuelling, S. Schneider and A. Vortkamp (2005). "Gli3 acts as a repressor 
downstream of Ihh in regulating two distinct steps of chondrocyte differentiation." Development 
132(23): 5249-5260. 
 
84 
 
Kronenberg, H. M. (2003). "Developmental regulation of the growth plate." Nature 423(6937): 
332-336. 
 
Kronenberg, H. M. (2006). "PTHrP and skeletal development." Ann N Y Acad Sci 1068: 1-13. 
 
Kuang, P. P., X. H. Zhang, C. B. Rich, J. A. Foster, M. Subramanian and R. H. Goldstein (2007). 
"Activation of elastin transcription by transforming growth factor-beta in human lung fibroblasts." 
Am J Physiol Lung Cell Mol Physiol 292(4): L944-952. 
Kuenzi, M. J. and O. D. Sherwood (1995). "Immunohistochemical localization of specific relaxin-
binding cells in the cervix, mammary glands, and nipples of pregnant rats." Endocrinology 
136(4): 1367-1373. 
 
Lavie, C. J., A. Sharma, M. A. Alpert, A. De Schutter, F. Lopez-Jimenez, R. V. Milani and H. O. 
Ventura (2016). "Update on Obesity and Obesity Paradox in Heart Failure." Prog Cardiovasc Dis 
58(4): 393-400. 
 
Lee, K., D. Brown, P. Urena, N. Ardaillou, R. Ardaillou, J. Deeds and G. V. Segre (1996). 
"Localization of parathyroid hormone/parathyroid hormone-related peptide receptor mRNA in 
kidney." Am J Physiol 270(1 Pt 2): F186-191. 
 
Li, H., P. K. Seitz, P. Selvanayagam, S. Rajaraman and C. W. Cooper (1996). "Effect of 
endogenously produced parathyroid hormone-related peptide on growth of a human hepatoma 
cell line (Hep G2)." Endocrinology 137(6): 2367-2374. 
 
Lippuner, K., H. J. Zehnder, J. P. Casez, R. Takkinen and P. Jaeger (1996). "PTH-related 
protein is released into the mother's bloodstream during lactation: evidence for beneficial effects 
on maternal calcium-phosphate metabolism." J Bone Miner Res 11(10): 1394-1399. 
 
Loveys, L. S., D. Gelb, S. R. Hurwitz, J. E. Puzas and R. N. Rosier (1993). "Effects of 
parathyroid hormone-related peptide on chick growth plate chondrocytes." J Orthop Res 11(6): 
884-891. 
 
Lucey, E. C., H. Q. Ngo, A. Agarwal, B. D. Smith, G. L. Snider and R. H. Goldstein (1996). 
"Differential expression of elastin and alpha 1(I) collagen mRNA in mice with bleomycin-induced 
pulmonary fibrosis." Lab Invest 74(1): 12-20. 
 
Maeda, S., R. L. Sutliff, J. Qian, J. N. Lorenz, J. Wang, H. Tang, T. Nakayama, C. Weber, D. 
Witte, A. R. Strauch, R. J. Paul, J. A. Fagin and T. L. Clemens (1999). "Targeted overexpression 
of parathyroid hormone-related protein (PTHrP) to vascular smooth muscle in transgenic mice 
lowers blood pressure and alters vascular contractility." Endocrinology 140(4): 1815-1825. 
 
Maeda, S., S. Wu, J. Green, H. Kim, R. Bosch, I. Lee, J. Adams, T. L. Clemens and I. Kurtz 
(1998). "The N-terminal portion of parathyroid hormone-related protein mediates the inhibition of 
apical Na+/H+ exchange in opossum kidney cells." J Am Soc Nephrol 9(2): 175-181. 
 
85 
 
Maeda, S., S. Wu, H. Juppner, J. Green, A. M. Aragay, J. A. Fagin and T. L. Clemens (1996). 
"Cell-specific signal transduction of parathyroid hormone (PTH)-related protein through stably 
expressed recombinant PTH/PTHrP receptors in vascular smooth muscle cells." Endocrinology 
137(8): 3154-3162. 
 
Maioli, E. and V. Fortino (2004). "PTHrP on MCF-7 breast cancer cells: a growth factor or an 
antimitogenic peptide?" Br J Cancer 90(6): 1293-1294; author reply 1295. 
 
Maioli, E., V. Fortino, C. Torricelli, B. Arezzini and C. Gardi (2002). "Effect of parathyroid 
hormone-related protein on fibroblast proliferation and collagen metabolism in human skin." Exp 
Dermatol 11(4): 302-310. 
 
Mannens, M., R. M. Slater, C. Heyting, A. Geurts van Kessel, E. Goedde-Salz, R. R. Frants, G. 
J. Van Ommen and P. L. Pearson (1987). "Regional localization of DNA probes on the short arm 
of chromosome 11 using aniridia-Wilms' tumor-associated deletions." Hum Genet 75(2): 180-
187. 
 
Mannstadt, M., H. Juppner and T. J. Gardella (1999). "Receptors for PTH and PTHrP: their 
biological importance and functional properties." Am J Physiol 277(5 Pt 2): F665-675. 
 
Martin, T. J., E. H. Allan, I. W. Caple, A. D. Care, J. A. Danks, H. Diefenbach-Jagger, P. R. 
Ebeling, M. T. Gillespie, G. Hammonds, J. A. Heath and et al. (1989). "Parathyroid hormone-
related protein: isolation, molecular cloning, and mechanism of action." Recent Prog Horm Res 
45: 467-502; discussion 502-466. 
 
Martin, T. J., J. M. Moseley and M. T. Gillespie (1991). "Parathyroid hormone-related protein: 
biochemistry and molecular biology." Crit Rev Biochem Mol Biol 26(3-4): 377-395. 
 
Massfelder, T., P. Dann, T. L. Wu, R. Vasavada, J. J. Helwig and A. F. Stewart (1997). 
"Opposing mitogenic and anti-mitogenic actions of parathyroid hormone-related protein in 
vascular smooth muscle cells: a critical role for nuclear targeting." Proc Natl Acad Sci U S A 
94(25): 13630-13635. 
 
Massfelder, T., N. Fiaschi-Taesch, A. F. Stewart and J. J. Helwig (1998). "Parathyroid hormone-
related peptide--a smooth muscle tone and proliferation regulatory protein." Curr Opin Nephrol 
Hypertens 7(1): 27-32. 
 
Massfelder, T., N. Parekh, K. Endlich, C. Saussine, M. Steinhausen and J. J. Helwig (1996). 
"Effect of intrarenally infused parathyroid hormone-related protein on renal blood flow and 
glomerular filtration rate in the anaesthetized rat." Br J Pharmacol 118(8): 1995-2000. 
 
Murer, H., N. Hernando, I. Forster and J. Biber (2003). "Regulation of Na/Pi transporter in the 
proximal tubule." Annu Rev Physiol 65: 531-542. 
 
Nemzek, J. A., K. M. Hugunin and M. R. Opp (2008). "Modeling sepsis in the laboratory: 
merging sound science with animal well-being." Comp Med 58(2): 120-128. 
86 
 
Nickols, G. A., A. D. Nana, M. A. Nickols, D. J. DiPette and G. K. Asimakis (1989). "Hypotension 
and cardiac stimulation due to the parathyroid hormone-related protein, humoral hypercalcemia 
of malignancy factor." Endocrinology 125(2): 834-841. 
 
Niedziela, J., B. Hudzik, N. Niedziela, M. Gasior, M. Gierlotka, J. Wasilewski, K. Myrda, A. 
Lekston, L. Polonski and P. Rozentryt (2014). "The obesity paradox in acute coronary syndrome: 
a meta-analysis." Eur J Epidemiol 29(11): 801-812. 
 
Oga, E. A. and O. R. Eseyin (2016). "The Obesity Paradox and Heart Failure: A Systematic 
Review of a Decade of Evidence." J Obes 2016: 9040248. 
 
Orloff, J. J., D. Reddy, A. E. de Papp, K. H. Yang, N. E. Soifer and A. F. Stewart (1994). 
"Parathyroid hormone-related protein as a prohormone: posttranslational processing and 
receptor interactions." Endocr Rev 15(1): 40-60. 
 
Philbrick, W. M., J. J. Wysolmerski, S. Galbraith, E. Holt, J. J. Orloff, K. H. Yang, R. C. 
Vasavada, E. C. Weir, A. E. Broadus and A. F. Stewart (1996). "Defining the roles of parathyroid 
hormone-related protein in normal physiology." Physiol Rev 76(1): 127-173. 
 
Pirola, C. J., H. M. Wang, A. Kamyar, S. Wu, H. Enomoto, B. Sharifi, J. S. Forrester, T. L. 
Clemens and J. A. Fagin (1993). "Angiotensin II regulates parathyroid hormone-related protein 
expression in cultured rat aortic smooth muscle cells through transcriptional and post-
transcriptional mechanisms." J Biol Chem 268(3): 1987-1994. 
 
Piserchio, A., T. Usdin and D. F. Mierke (2000). "Structure of tuberoinfundibular peptide of 39 
residues." J Biol Chem 275(35): 27284-27290. 
 
Poncelas, M., J. Inserte, U. Vilardosa, A. Rodriguez-Sinovas, J. Baneras, R. Simo and D. 
Garcia-Dorado (2015). "Obesity induced by high fat diet attenuates postinfarct myocardial 
remodeling and dysfunction in adult B6D2F1 mice." J Mol Cell Cardiol 84: 154-161. 
 
Qian, J., J. N. Lorenz, S. Maeda, R. L. Sutliff, C. Weber, T. Nakayama, M. C. Colbert, R. J. Paul, 
J. A. Fagin and T. L. Clemens (1999). "Reduced blood pressure and increased sensitivity of the 
vasculature to parathyroid hormone-related protein (PTHrP) in transgenic mice overexpressing 
the PTH/PTHrP receptor in vascular smooth muscle." Endocrinology 140(4): 1826-1833. 
 
Rehan, V. K., R. Sakurai, Y. Wang, J. Santos, K. Huynh and J. S. Torday (2007). "Reversal of 
nicotine-induced alveolar lipofibroblast-to-myofibroblast transdifferentiation by stimulants of 
parathyroid hormone-related protein signalling." Lung 185(3): 151-159. 
 
Rehan, V. K., Y. Wang, S. Sugano, S. Romero, X. Chen, J. Santos, A. Khazanchi and J. S. 
Torday (2005). "Mechanism of nicotine-induced pulmonary fibroblast transdifferentiation." Am J 
Physiol Lung Cell Mol Physiol 289(4): L667-676. 
 
Rodrigues, S. F. and D. N. Granger (2010). "Role of blood cells in ischaemia-reperfusion 
induced endothelial barrier failure." Cardiovasc Res 87(2): 291-299. 
87 
 
Rutter, W. J., R. L. Pictet, J. D. Harding, J. M. Chirgwin, R. J. MacDonald and A. E. Przybyla 
(1978). "An analysis of pancreatic development: role of mesenchymal factor and other 
extracellular factors." Symp Soc Dev Biol(35): 205-227. 
 
Schluter, K. D. (1999). "PTH and PTHrP: Similar Structures but Different Functions." News 
Physiol Sci 14: 243-249. 
 
Schluter, K. D. and H. M. Piper (1998). "Cardiovascular actions of parathyroid hormone and 
parathyroid hormone-related peptide." Cardiovasc Res 37(1): 34-41. 
 
Schluter, K. D., M. Weber and H. M. Piper (1995). "Parathyroid hormone induces protein kinase 
C but not adenylate cyclase in adult cardiomyocytes and regulates cyclic AMP levels via protein 
kinase C-dependent phosphodiesterase activity." Biochem J 310 ( Pt 2): 439-444. 
 
Schluter, K. D., M. Weber and H. M. Piper (1997). "Effects of PTH-rP(107-111) and PTH-rP(7-
34) on adult cardiomyocytes." J Mol Cell Cardiol 29(11): 3057-3065. 
 
Schmidt, D. S. and A. K. Salahudeen (2007). "Obesity-survival paradox-still a controversy?" 
Semin Dial 20(6): 486-492. 
 
Schultz, C. J., E. Torres, C. Londos and J. S. Torday (2002). "Role of adipocyte differentiation-
related protein in surfactant phospholipid synthesis by type II cells." Am J Physiol Lung Cell Mol 
Physiol 283(2): L288-296. 
 
Schwarzl, M., S. Seiler, M. Wallner, D. von Lewinski, S. Huber, H. Maechler, P. Steendijk, S. 
Zelzer, M. Truschnig-Wilders, B. Obermayer-Pietsch, A. Lueger, B. M. Pieske and H. Post 
(2013). "Mild hypothermia attenuates circulatory and pulmonary dysfunction during experimental 
endotoxemia." Crit Care Med 41(12): e401-410. 
 
Soifer, N. E., K. E. Dee, K. L. Insogna, W. J. Burtis, L. M. Matovcik, T. L. Wu, L. M. Milstone, A. 
E. Broadus, W. M. Philbrick and A. F. Stewart (1992). "Parathyroid hormone-related protein. 
Evidence for secretion of a novel mid-region fragment by three different cell types." J Biol Chem 
267(25): 18236-18243. 
 
Song, G. J., N. Fiaschi-Taesch and A. Bisello (2009). "Endogenous parathyroid hormone-related 
protein regulates the expression of PTH type 1 receptor and proliferation of vascular smooth 
muscle cells." Mol Endocrinol 23(10): 1681-1690. 
 
Stern, J. B., O. Bernard, C. Paugam, C. Silve, J. Mantz, M. Aubier and B. Crestani (2002). 
"Parathyroid hormone-related protein in epithelial lining fluid in humans negatively correlates 
with the severity of lung injury." Chest 121(3): 852-857. 
 
Strewler, G. J. (2000). "The physiology of parathyroid hormone-related protein." N Engl J Med 
342(3): 177-185. 
 
88 
 
Suva, L. J., K. A. Mather, M. T. Gillespie, G. C. Webb, K. W. Ng, G. A. Winslow, W. I. Wood, T. 
J. Martin and P. J. Hudson (1989). "Structure of the 5' flanking region of the gene encoding 
human parathyroid-hormone-related protein (PTHrP)." Gene 77(1): 95-105. 
 
Suva, L. J., G. A. Winslow, R. E. Wettenhall, R. G. Hammonds, J. M. Moseley, H. Diefenbach-
Jagger, C. P. Rodda, B. E. Kemp, H. Rodriguez, E. Y. Chen and et al. (1987). "A parathyroid 
hormone-related protein implicated in malignant hypercalcemia: cloning and expression." 
Science 237(4817): 893-896. 
 
Takahashi, K., D. Inoue, K. Ando, T. Matsumoto, K. Ikeda and T. Fujita (1995). "Parathyroid 
hormone-related peptide as a locally produced vasorelaxant: regulation of its mRNA by 
hypertension in rats." Biochem Biophys Res Commun 208(1): 447-455. 
 
Torday, J. S. (2014). "On the evolution of development." Trends Dev Biol 8: 17-37. 
 
Torday, J. S. and V. K. Rehan (2002). "Stretch-stimulated surfactant synthesis is coordinated by 
the paracrine actions of PTHrP and leptin." Am J Physiol Lung Cell Mol Physiol 283(1): L130-
135. 
 
Torday, J. S. and V. K. Rehan (2004). "Deconvoluting lung evolution using 
functional/comparative genomics." Am J Respir Cell Mol Biol 31(1): 8-12. 
 
Torday, J. S. and V. K. Rehan (2007). "The evolutionary continuum from lung development to 
homeostasis and repair." Am J Physiol Lung Cell Mol Physiol 292(3): L608-611. 
 
Torday, J. S., H. Sun, L. Wang, E. Torres, M. E. Sunday and L. P. Rubin (2002). "Leptin 
mediates the parathyroid hormone-related protein paracrine stimulation of fetal lung maturation." 
Am J Physiol Lung Cell Mol Physiol 282(3): L405-410. 
 
Torday, J. S., E. Torres and V. K. Rehan (2003). "The role of fibroblast transdifferentiation in 
lung epithelial cell proliferation, differentiation, and repair in vitro." Pediatr Pathol Mol Med 22(3): 
189-207. 
 
Turer, A. T. and J. A. Hill (2010). "Pathogenesis of myocardial ischemia-reperfusion injury and 
rationale for therapy." Am J Cardiol 106(3): 360-368. 
 
Usdin, T. B., T. I. Bonner, G. Harta and E. Mezey (1996). "Distribution of parathyroid hormone-2 
receptor messenger ribonucleic acid in rat." Endocrinology 137(10): 4285-4297. 
 
Usdin, T. B., C. Gruber and T. I. Bonner (1995). "Identification and functional expression of a 
receptor selectively recognizing parathyroid hormone, the PTH2 receptor." J Biol Chem 270(26): 
15455-15458. 
 
Usdin, T. B., T. Wang, S. R. Hoare, E. Mezey and M. Palkovits (2000). "New members of the 
parathyroid hormone/parathyroid hormone receptor family: the parathyroid hormone 2 receptor 
and tuberoinfundibular peptide of 39 residues." Front Neuroendocrinol 21(4): 349-383. 
89 
 
VanHouten, J., P. Dann, G. McGeoch, E. M. Brown, K. Krapcho, M. Neville and J. J. 
Wysolmerski (2004). "The calcium-sensing receptor regulates mammary gland parathyroid 
hormone-related protein production and calcium transport." J Clin Invest 113(4): 598-608. 
 
Vanhouten, J. N. and J. J. Wysolmerski (2013). "The calcium-sensing receptor in the breast." 
Best Pract Res Clin Endocrinol Metab 27(3): 403-414. 
 
Vendrell, J., M. Broch, N. Vilarrasa, A. Molina, J. M. Gomez, C. Gutierrez, I. Simon, J. Soler and 
C. Richart (2004). "Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: 
relationships in obesity." Obes Res 12(6): 962-971. 
 
Vinten-Johansen, J. and W. Shi (2011). "Perconditioning and postconditioning: current 
knowledge, knowledge gaps, barriers to adoption, and future directions." J Cardiovasc 
Pharmacol Ther 16(3-4): 260-266. 
 
Wang, L., W. Liu, X. He, Y. Chen, J. Lu, K. Liu, K. Cao and P. Yin (2016). "Association of 
overweight and obesity with patient mortality after acute myocardial infarction: a meta-analysis of 
prospective studies." Int J Obes (Lond) 40(2): 220-228. 
 
Wysolmerski, J. J., S. Cormier, W. M. Philbrick, P. Dann, J. P. Zhang, J. Roume, A. L. Delezoide 
and C. Silve (2001). "Absence of functional type 1 parathyroid hormone (PTH)/PTH-related 
protein receptors in humans is associated with abnormal breast development and tooth 
impaction." J Clin Endocrinol Metab 86(4): 1788-1794. 
 
Zhao, L., P. J. Roche, J. M. Gunnersen, V. E. Hammond, G. W. Tregear, E. M. Wintour and F. 
Beck (1999). "Mice without a functional relaxin gene are unable to deliver milk to their pups." 
Endocrinology 140(1): 445-453. 
 
 
 
 
 
 
 
 
 
90 
 
10. List of Publications 
Oruqaj L, Forst S, Schreckenberg R, Inserte J, Poncelas M, Bañeras J, Garcia-Dorado 
D, Rohrbach S, Schlüter KD. Effect of high fat diet on pulmonary expression of parathyroid 
hormone-related protein and its downstream targets. Heliyon. 2016 Oct 27;2(10):e00182. 
eCollection 2016. 
 
In preparation: 
Learta Oruqaj, Rolf Schreckenberg, Heiner Post, Michael Schwarzl, Burkert Mathias Pieske, 
Klaus-Dieter Schlüter. Effect of mild hypothermia on regional expression of parathyroid 
hormone-related peptide (PTHrP) in experimental endotoxemia 
 
 
 
 
 
 
 
 
 
 
 
 
91 
 
11. Declaration of Original Work 
I, Learta Pervizaj Oruqaj declare that the work presented in this thesis exhibits the results of my 
original research work. 
The thesis entitled ‘Effect of pathophysiological stressors on the tissue expression of parathyroid 
hormone-related protein (PTHrP)’ was performed in the period between February 2012 until 
2015 at the Institute of Physiology, Faculty of Medicine, Justus-Liebig University, Gießen. 
I corroborate that, for the literature I consulted, the references are given, and I acknowledged all 
people, which contributed to accomplish this thesis work. 
 
 
 
Gießen, 04.04. 2016                                                                                 Learta Pervizaj Oruqaj 
 
 
 
 
 
 
 
 
 
 
 
92 
 
12. Acknowledgements 
I would like to express my special appreciation to my supervisor Prof. Dr. Klaus-Dieter Schlüter. 
Thanks for your endless support, guidance through these three years and your efforts to 
encourage and allow me to fulfill my desire to become a research scientist. 
Prof. Schlüter is a person you will immediately love and always have fun when you talk to him. I 
consider him as one of the most intelligent people I have ever met. I hope that I could see myself 
in the future as active, energetic, patient, lovely, and polite as my supervisor, and be able to lead 
a research group likewise. He is my role model. 
Many thanks, to Dr. Rolf Schreckenberg for his valuable suggestions and for sharing his 
scientific knowledge with me. Thanks a lot for good advice. 
I am very grateful to Prof. David Garcia-Dorado and his research group for cardiovascular 
diseases, Institute de Recerca, Hospital Universitari Barcelona, Spain for their proper 
collaboration. 
Special thanks to Dr. Heiner Post, Medical University of Graz, Austria for collaboration and keen 
interest to accomplish this work successfully.  
I acknowledge with gratitude to Prof. Dr. Klaus Preissner for giving me the chance to be member 
of “PROMISE” (Protecting the Heart from Ischemia), International Research Training Group 
1566 Giessen – Barcelona. Our interactive talks on Fridays together with all “PROMISE” 
members in Gießen, as well as conferences held together with other research groups from 
Germany and Barcelona had an immense importance for our research. 
Sincere thanks to the technical staff, especially to Nadine Woitasky and Peter Volk whose 
enormous and excellent work made my progress feasible throughout these years.  
I particularly want to thank my fellow doctoral students at the Institute of Physiology. Besides 
sharing the same working environment, we became good friends also. Thanks for your kindness 
and cooperation. The event of „Plätzchen backen“, and celebration the Christmas all together, 
will be memorable for me. 
I especially appreciate my family for their unlimited love and support constantly. Confidently, I 
promise you that I am going to spend more time with you all hereafter. Being abroad since I was 
18 years old, provided me awesome experience in all respects but also gave me more maturity. I 
93 
hope that I will have the opportunity to contribute in our homeland and build a better future for 
people there.  
I owe my deepest gratitude to my husband, who helped me overcome every trouble I have had, 
and made me extraordinarily happy. I am truly blessed to have you in my life. 
Finally, I would like to acknowledge the financial and technical support of the Institute of 
Physiology, Justus-Liebig University, and “PROMISE” IRTG Gießen-Barcelona (implemented by 
Deutsche Forschungsgemeinschaft). 
Der Lebenslauf wurde aus der elektronischen 
Version der Arbeit entfernt.
The curriculum vitae was removed from the 
electronic version of the paper. 
VVB
INAUGURAL-DISSERTATION 
submitted for the Degree of 
Doctor of Human Biology 
at Faculty of Medicine, 
Justus Liebig University, Gießen
VVB LAUFERSWEILER VERLAG
STAUFENBERGRING 15
D-35396 GIESSEN
Tel: 0641-5599888 Fax: -5599890
redaktion@doktorverlag.de
www.doktorverlag.de
VVB LAUFERSWEILER VERLAG
édition scientifique
9 7 8 3 8 3 5 9 6 5 1 9 5
ISBN: 978-3-8359-6519-5
L
E
A
R
T
A
 
P
.
O
R
U
Q
A
J
 
 
 
E
F
F
E
C
T
 
O
F
 
P
A
T
H
O
P
H
Y
S
.
 
S
T
R
E
S
S
O
R
S
 
O
N
 
T
H
E
 
E
X
P
R
E
S
S
I
O
N
 
O
F
 
P
T
H
r
P
Learta Pervizaj Oruqaj
Effect of pathophysiological stressors 
on the tissue expression of parathyroid 
hormone-related protein (PTHrP)
Photo cover: © 
VVB
VERLAG
VVB
VVB LAUFERSWEILER VERLAG
édition scientifique
